# EDGAR Filing Document

**Accession Number:** 0000827054
**File Stem:** 0000827054-23-000020
**Filing Date:** 2023-2
**Character Count:** 288414
**Document Hash:** 066d429cad16def38bb0bbe178ef0f9c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000827054-23-000020.hdr.sgml**: 20230202

**ACCESSION NUMBER**: 0000827054-23-000020

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 79

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230202

**DATE AS OF CHANGE**: 20230202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MICROCHIP TECHNOLOGY INC
- **CENTRAL INDEX KEY:** 0000827054
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 860629024
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21184
- **FILM NUMBER:** 23581258

**BUSINESS ADDRESS:**
- **STREET 1:** 2355 W CHANDLER BLVD
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85224-6199
- **BUSINESS PHONE:** 480-792-7200

**MAIL ADDRESS:**
- **STREET 1:** 2355 WEST CHANDLER BLVD
- **CITY:** CHANDLER
- **STATE:** AZ
- **ZIP:** 85224-6199

?xml version="1.0" ? mchp-20221231

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended December 31, 2022

OR

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from __________ to __________

Commission File Number: 0-21184

![mchp-20221231_g1.jpg](mchp-20221231_g1.jpg)

**MICROCHIP TECHNOLOGY INCORPORATED** 

(Exact Name of Registrant as Specified in Its Charter)

---

| | |
|:---|:---|
| **<u>Delaware</u>** | **<u>86-0629024</u>** |
| (State or Other Jurisdiction of Incorporation or Organization) | (IRS Employer Identification No.) |

---

**2355 W. Chandler Blvd., Chandler, AZ 85224-6199** 

(Address of Registrant's Principal Executive Offices)

**(480) 792-7200** 

(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of Each Class</u>** |  **<u>Trading Symbol(s)</u>** | **<u>Name of Each Exchange on Which Registered</u>** |
| Common Stock, $0.001 par value | MCHP | NASDAQ Stock Market LLC |
|  |  | (Nasdaq Global Select Market) |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act:

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

The number of shares outstanding of the registrant's Common Stock, $0.001 par value, as of January 26, 2023 was 547,795,897.

------

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES**

**INDEX**

---

| | | |
|:---|:---|:---|
| **PART I. FINANCIAL INFORMATION** | **PART I. FINANCIAL INFORMATION** | **PART I. FINANCIAL INFORMATION** |
| &nbsp;&nbsp;[Item 1.](#i32521453983b4a318e7d58b6f396f928_13) | [Financial Statements (Unaudited)](#i32521453983b4a318e7d58b6f396f928_13) |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Balance Sheets – December 31, 2022 and March 31, 2022](#i32521453983b4a318e7d58b6f396f928_16) | [4](#i32521453983b4a318e7d58b6f396f928_16) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Statements of Income – Three and Nine Months Ended December 31, 2022 and 2021](#i32521453983b4a318e7d58b6f396f928_19) | [5](#i32521453983b4a318e7d58b6f396f928_19) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended December 31, 2022 and 2021](#i32521453983b4a318e7d58b6f396f928_22) | [6](#i32521453983b4a318e7d58b6f396f928_22) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Statements of Cash Flows – Nine Months Ended December 31, 2022 and 2021](#i32521453983b4a318e7d58b6f396f928_25) | [7](#i32521453983b4a318e7d58b6f396f928_25) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Condensed Consolidated Statements of Changes in Equity - Three and Nine Months Ended December 31, 2022 and 2021](#i32521453983b4a318e7d58b6f396f928_28) | [8](#i32521453983b4a318e7d58b6f396f928_28) |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[Notes to Condensed Consolidated Financial Statements](#i32521453983b4a318e7d58b6f396f928_31) | [10](#i32521453983b4a318e7d58b6f396f928_31) |
| &nbsp;&nbsp;[Item 2.](#i32521453983b4a318e7d58b6f396f928_175) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#i32521453983b4a318e7d58b6f396f928_175) | [24](#i32521453983b4a318e7d58b6f396f928_175) |
| &nbsp;&nbsp;[Item 3.](#i32521453983b4a318e7d58b6f396f928_223) | [Quantitative and Qualitative Disclosures About Market Risk](#i32521453983b4a318e7d58b6f396f928_223) | [35](#i32521453983b4a318e7d58b6f396f928_223) |
| &nbsp;&nbsp;[Item 4.](#i32521453983b4a318e7d58b6f396f928_226) | [Controls and Procedures](#i32521453983b4a318e7d58b6f396f928_226) | [36](#i32521453983b4a318e7d58b6f396f928_226) |
| **PART II. OTHER INFORMATION** | **PART II. OTHER INFORMATION** | **PART II. OTHER INFORMATION** |
| &nbsp;&nbsp;[Item 1.](#i32521453983b4a318e7d58b6f396f928_232) | [Legal Proceedings](#i32521453983b4a318e7d58b6f396f928_232) | [37](#i32521453983b4a318e7d58b6f396f928_232) |
| &nbsp;&nbsp;[Item 1A.](#i32521453983b4a318e7d58b6f396f928_235) | [Risk Factors](#i32521453983b4a318e7d58b6f396f928_235) | [37](#i32521453983b4a318e7d58b6f396f928_235) |
| &nbsp;&nbsp;[Item 2.](#i32521453983b4a318e7d58b6f396f928_238) | [Unregistered Sales of Equity Securities and Use of Proceeds](#i32521453983b4a318e7d58b6f396f928_238) | [56](#i32521453983b4a318e7d58b6f396f928_238) |
| &nbsp;&nbsp;[Item 3.](#i32521453983b4a318e7d58b6f396f928_241) | [Defaults Upon Senior Securities](#i32521453983b4a318e7d58b6f396f928_241) | [56](#i32521453983b4a318e7d58b6f396f928_241) |
| &nbsp;&nbsp;[Item 4.](#i32521453983b4a318e7d58b6f396f928_244) | [Mine Safety Disclosures](#i32521453983b4a318e7d58b6f396f928_244) | [56](#i32521453983b4a318e7d58b6f396f928_244) |
| &nbsp;&nbsp;[Item 5.](#i32521453983b4a318e7d58b6f396f928_247) | [Other Information](#i32521453983b4a318e7d58b6f396f928_247) | [56](#i32521453983b4a318e7d58b6f396f928_247) |
| &nbsp;&nbsp;[Item 6.](#i32521453983b4a318e7d58b6f396f928_250) | [Exhibits](#i32521453983b4a318e7d58b6f396f928_250) | [57](#i32521453983b4a318e7d58b6f396f928_250) |
|  | [Signatures](#i32521453983b4a318e7d58b6f396f928_253) |  |

---

------

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES**

**Defined Terms**<sup>(1)</sup>

---

| | |
|:---|:---|
| **Term** | **Definition** |
| 4.333% 2023 Notes | 2023 Senior Unsecured Notes, maturing June 1, 2023 |
| 2.670% 2023 Notes | 2023 Senior Unsecured Notes, maturing September 1, 2023 |
| 0.972% 2024 Notes | 2024 Senior Unsecured Notes, maturing February 15, 2024 |
| 0.983% 2024 Notes | 2024 Senior Unsecured Notes, maturing September 1, 2024 |
| 4.250% 2025 Notes | 2025 Senior Unsecured Notes, maturing September 1, 2025 |
| 2015 Senior Convertible Debt | 2015 Senior Convertible Debt, maturing February 15, 2025 |
| 2017 Senior Convertible Debt | 2017 Senior Convertible Debt, maturing February 15, 2027 |
| 2020 Senior Convertible Debt | 2020 Senior Convertible Debt, maturing November 15, 2024 |
| 2017 Junior Convertible Debt | 2017 Junior Convertible Debt, maturing February 15, 2037 |
| ASU | Accounting Standards Update |
| CEMs | Client engagement managers |
| CHIPS Act | CHIPS and Science Act of 2022 |
| Convertible Debt | 2015 Senior Convertible Debt, 2017 Senior Convertible Debt, 2020 Senior Convertible Debt, and 2017 Junior Convertible Debt |
| Credit Agreement | Amended and Restated Credit Agreement, dated as of December 16, 2021, among the Company, as borrower, the lenders from time to time party thereto, and J.P. Morgan Chase Bank, N.A., as administrative agent |
| EAR | Export Administration Regulation |
| ESEs | Embedded solutions engineers |
| Exchange Act | Securities Exchange Act of 1934, as amended |
| FASB | Financial Accounting Standards Board |
| FPGA | Field-programmable gate array |
| OEMs | Original equipment manufacturers |
| R&D | Research and development |
| Revolving Credit Facility | $2.75 billion revolving credit facility created pursuant to the Credit Agreement |
| RSUs | Restricted stock units |
| SARs | Stock appreciation rights |
| SEC | U.S. Securities and Exchange Commission |
| Senior Indebtedness | Revolving Credit Facility, 3.922% 2021 Notes, 4.333% 2023 Notes, 2.670% 2023 Notes, 0.972% 2024 Notes, 0.983% 2024 Notes, and 4.250% 2025 Notes |
| Senior Notes | 3.922% 2021 Notes, 4.333% 2023 Notes, 2.670% 2023 Notes, 0.972% 2024 Notes, 0.983% 2024 Notes, and 4.250% 2025 Notes |
| TCJA | Tax Cuts and Jobs Act of 2017 |
| U.S. GAAP | U.S. Generally Accepted Accounting Principles |

---

<sup>(1)</sup> Certain terms used within this Form 10-Q are defined in the above table.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**PART I. FINANCIAL INFORMATION**

**Item 1**. **Financial Statements**

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

(in millions, except share and per share amounts; unaudited)

---

| | | |
|:---|:---|:---|
| **ASSETS** | **ASSETS** | **ASSETS** |
|  | December 31, | March 31, |
|  | 2022 | 2022 |
| Cash and cash equivalents | $288.9 | $317.4 |
| Short-term investments |  | 2.0 |
| Accounts receivable, net | 1175.0 | 1072.6 |
| Inventories | 1165.4 | 854.4 |
| Other current assets | 204.4 | 206.2 |
| Total current assets | 2833.7 | 2452.6 |
| Property, plant and equipment, net | 1113.7 | 967.9 |
| Goodwill | 6673.6 | 6673.6 |
| Intangible assets, net | 3544.8 | 4043.1 |
| Long-term deferred tax assets | 1630.0 | 1797.1 |
| Other assets | 320.3 | 265.2 |
| Total assets | $16116.1 | $16199.5 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** | **LIABILITIES AND STOCKHOLDERS' EQUITY** | **LIABILITIES AND STOCKHOLDERS' EQUITY** |
| Accounts payable | $354.8 | $344.7 |
| Accrued liabilities | 1256.3 | 1054.3 |
| Total current liabilities | 1611.1 | 1399.0 |
| Long-term debt | 6588.7 | 7687.4 |
| Long-term income tax payable | 660.3 | 704.6 |
| Long-term deferred tax liability | 40.3 | 39.8 |
| Other long-term liabilities | 904.1 | 473.9 |
| Stockholders' equity: |  |  |
| Preferred stock, $0.001 par value; authorized 5,000,000 shares; no shares issued or outstanding |  |  |
| Common stock, $0.001 par value; authorized 900,000,000 shares; 577,805,496 shares issued and 547,792,012 shares outstanding at December 31, 2022; 577,805,396 shares issued and 554,500,524 shares outstanding at March 31, 2022 | 0.5 | 0.6 |
| Additional paid-in capital | 2380.4 | 2535.9 |
| Common stock held in treasury: 30,013,484 shares at December 31, 2022; 23,304,872 shares at March 31, 2022 | (1407.8) | (796.3) |
| Accumulated other comprehensive loss | (17.5) | (20.6) |
| Retained earnings | 5356.0 | 4175.2 |
| Total stockholders' equity | 6311.6 | 5894.8 |
| Total liabilities and stockholders' equity | $16116.1 | $16199.5 |

---

See accompanying notes to condensed consolidated financial statements

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

(in millions, except per share amounts; unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Net sales | $2169.2 | $1757.5 | $6206.0 | $4976.7 |
| Cost of sales | 698.4 | 604.2 | 2027.4 | 1747.5 |
| Gross profit | 1470.8 | 1153.3 | 4178.6 | 3229.2 |
| Research and development | 282.4 | 245.4 | 820.0 | 730.0 |
| Selling, general and administrative | 202.9 | 177.5 | 594.2 | 531.7 |
| Amortization of acquired intangible assets | 167.4 | 215.7 | 502.5 | 647.0 |
| Special charges (income) and other, net | 6.5 | (0.3) | (6.1) | 20.4 |
| Operating expenses | 659.2 | 638.3 | 1910.6 | 1929.1 |
| Operating income | 811.6 | 515.0 | 2268.0 | 1300.1 |
| Interest income | 0.8 | 0.1 | 1.1 | 0.5 |
| Interest expense | (52.8) | (62.1) | (156.4) | (199.2) |
| Loss on settlement of debt |  | (16.1) | (8.3) | (101.6) |
| Other income, net | 2.6 | 4.6 | 3.5 | 3.5 |
| Income before income taxes | 762.2 | 441.5 | 2107.9 | 1003.3 |
| Income tax provision | 181.9 | 88.7 | 474.2 | 155.7 |
| Net income | $580.3 | $352.8 | $1633.7 | $847.6 |
| Basic net income per common share | $1.06 | $0.64 | $2.96 | $1.54 |
| Diluted net income per common share | $1.04 | $0.62 | $2.93 | $1.50 |
| Dividends declared per common share | $0.3280 | $0.2320 | $0.9050 | $0.6570 |
| Basic common shares outstanding | 549.2 | 554.9 | 551.5 | 551.2 |
| Diluted common shares outstanding | 555.4 | 567.3 | 558.4 | 566.1 |

---

See accompanying notes to condensed consolidated financial statements

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

(in millions; unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Net income | $580.3 | $352.8 | $1633.7 | $847.6 |
| Components of other comprehensive (loss) income: |  |  |  |  |
| Defined benefit plans: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Actuarial (losses) gains related to defined benefit pension plans, net of tax effect | (6.0) | 2.1 | 2.9 | 2.8 |
| &nbsp;&nbsp;&nbsp;Reclassification of realized transactions, net of tax effect | 0.1 | 0.6 | 0.3 | 1.8 |
| Change in net foreign currency translation adjustment |  | (1.6) | (0.1) | (1.7) |
| Other comprehensive (loss) income, net of tax effect | (5.9) | 1.1 | 3.1 | 2.9 |
| Comprehensive income | $574.4 | $353.9 | $1636.8 | $850.5 |

---

See accompanying notes to condensed consolidated financial statements

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(in millions; unaudited)

---

| | | |
|:---|:---|:---|
| | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 |
| Cash flows from operating activities: |  |  |
| Net income | $1633.7 | $847.6 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 755.2 | 850.3 |
| &nbsp;&nbsp;Deferred income taxes | 185.4 | 6.1 |
| &nbsp;&nbsp;Share-based compensation expense related to equity incentive plans | 126.5 | 163.2 |
| &nbsp;&nbsp;Loss on settlement of debt | 8.3 | 101.6 |
| &nbsp;&nbsp;Amortization of debt discount | 5.4 | 34.9 |
| &nbsp;&nbsp;Amortization of debt issuance costs | 7.1 | 9.2 |
| &nbsp;&nbsp;Impairment of intangible assets | 1.4 |  |
| &nbsp;&nbsp;Other non-cash adjustment | (1.8) | (9.5) |
| &nbsp;&nbsp;Changes in operating assets and liabilities, excluding impact of acquisitions: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in accounts receivable | (102.4) | 67.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in inventories | (324.8) | (105.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in accounts payable and accrued liabilities | 225.5 | 73.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in other assets and liabilities | 408.0 | 30.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in income tax payable | (16.0) | 24.9 |
| Net cash provided by operating activities | 2911.5 | 2095.0 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;Proceeds from sales of assets | 0.4 | 12.2 |
| &nbsp;&nbsp;Investments in other assets | (75.6) | (91.7) |
| &nbsp;&nbsp;Capital expenditures | (373.5) | (255.5) |
| Net cash used in investing activities | (448.7) | (335.0) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;Proceeds from borrowings on Revolving Credit Facility | 4021.0 | 2947.0 |
| &nbsp;&nbsp;Repayments of Revolving Credit Facility | (5167.1) | (3753.5) |
| &nbsp;&nbsp;Proceeds from issuance of senior notes |  | 997.0 |
| &nbsp;&nbsp;Repayment of senior notes |  | (1000.0) |
| &nbsp;&nbsp;Payments on settlement of convertible debt | (170.4) | (359.8) |
| &nbsp;&nbsp;Deferred financing costs |  | (7.8) |
| &nbsp;&nbsp;Proceeds from sale of common stock | 54.3 | 47.1 |
| &nbsp;&nbsp;Tax payments related to shares withheld for vested RSUs | (57.2) | (66.9) |
| &nbsp;&nbsp;Repurchase of common stock | (671.9) | (166.0) |
| &nbsp;&nbsp;Payment of cash dividends | (499.4) | (363.0) |
| &nbsp;&nbsp;Capital lease payments | (0.6) | (0.6) |
| Net cash used in financing activities | (2491.3) | (1726.5) |
| Net (decrease) increase in cash and cash equivalents | (28.5) | 33.5 |
| Cash and cash equivalents, and restricted cash at beginning of period | 317.4 | 280.0 |
| Cash and cash equivalents, and restricted cash at end of period | $288.9 | $313.5 |

---

See accompanying notes to condensed consolidated financial statements

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY**

(in millions; unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock and Additional Paid-in-Capital | Common Stock and Additional Paid-in-Capital | Common Stock Held in Treasury | Common Stock Held in Treasury | Accumulated Other Comprehensive Loss | Retained Earnings | Total Equity |
| | Shares | Amount | Shares | Amount | Accumulated Other Comprehensive Loss | Retained Earnings | Total Equity |
| Balance at March 31, 2021 | 569.0 | $2403.6 | 21.9 | $(433.8) | $(26.2) | $3393.5 | $5337.1 |
| Net income |  |  |  |  |  | 252.8 | 252.8 |
| Other comprehensive income |  |  |  |  |  |  |  |
| Proceeds from sales of common stock through employee equity incentive plans | 1.4 | 12.2 |  |  |  |  | 12.2 |
| RSU and SAR withholdings | (0.4) | (25.3) |  |  |  |  | (25.3) |
| Treasury stock used for new issuances | (1.0) | (16.3) | (1.0) | 16.3 |  |  |  |
| Share-based compensation |  | 56.2 |  |  |  |  | 56.2 |
| Cash dividend |  |  |  |  |  | (113.1) | (113.1) |
| Balance at June 30, 2021 | 569.0 | 2430.4 | 20.9 | (417.5) | (26.2) | 3533.2 | 5519.9 |
| Net Income |  |  |  |  |  | 242.0 | 242.0 |
| Other comprehensive income |  |  |  |  | 1.8 |  | 1.8 |
| Proceeds from sales of common stock through employee equity incentive plans | 1.6 | 21.2 |  |  |  |  | 21.2 |
| RSU and SAR withholdings | (0.3) | (23.8) |  |  |  |  | (23.8) |
| Treasury stock used for new issuances | (1.3) | (19.6) | (1.3) | 19.6 |  |  |  |
| Shares issued to settle convertible debt | 5.4 | 399.2 |  |  |  |  | 399.2 |
| Settlement of convertible debt |  | (391.1) |  |  |  |  | (391.1) |
| Share-based compensation |  | 54.9 |  |  |  |  | 54.9 |
| Cash dividend |  |  |  |  |  | (121.2) | (121.2) |
| Balance at September 30, 2021 | 574.4 | 2471.2 | 19.6 | (397.9) | (24.4) | 3654.0 | 5702.9 |
| Net income |  |  |  |  |  | 352.8 | 352.8 |
| Other comprehensive income |  |  |  |  | 1.1 |  | 1.1 |
| Proceeds from sales of common stock through employee equity incentive plans | 1.0 | 13.7 |  |  |  |  | 13.7 |
| RSU and SAR withholdings | (0.2) | (17.8) |  |  |  |  | (17.8) |
| Treasury stock used for new issuances | (0.8) | (11.2) | (0.8) | 11.2 |  |  |  |
| Repurchase of common stock |  |  | 2.0 | (166.0) |  |  | (166.0) |
| Shares issued to settle convertible debt | 2.4 | 196.9 |  |  |  |  | 196.9 |
| Settlement of convertible debt |  | (201.9) |  |  |  |  | (201.9) |
| Share-based compensation |  | 50.3 |  |  |  |  | 50.3 |
| Cash dividend |  |  |  |  |  | (128.7) | (128.7) |
| Balance at December 31, 2021 | 576.8 | $2501.2 | 20.8 | $(552.7) | $(23.3) | $3878.1 | $5803.3 |
| Balance at March 31, 2022 | 577.8 | $2536.5 | 23.3 | $(796.3) | $(20.6) | $4175.2 | $5894.8 |
| Adoption of ASU 2020-06, cumulative adjustment |  | (128.3) |  |  |  | 46.5 | (81.8) |
| Net income |  |  |  |  |  | 507.2 | 507.2 |
| Other comprehensive income |  |  |  |  | 4.0 |  | 4.0 |
| Proceeds from sales of common stock through employee equity incentive plans | 1.2 | 13.4 |  |  |  |  | 13.4 |
| RSU and SAR withholdings | (0.3) | (19.4) |  |  |  |  | (19.4) |
| Treasury stock used for new issuances | (0.9) | (16.5) | (0.9) | 16.5 |  |  |  |

---

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Common Stock and Additional Paid-in-Capital | Common Stock and Additional Paid-in-Capital | Common Stock Held in Treasury | Common Stock Held in Treasury | Accumulated Other Comprehensive Loss | Retained Earnings | Total Equity |
| | Shares | Amount | Shares | Amount | Accumulated Other Comprehensive Loss | Retained Earnings | Total Equity |
| Repurchase of common stock |  |  | 2.9 | (195.2) |  |  | (195.2) |
| Settlement of convertible debt |  | (32.9) |  |  |  |  | (32.9) |
| Share-based compensation |  | 40.8 |  |  |  |  | 40.8 |
| Cash dividend |  |  |  |  |  | (153.0) | (153.0) |
| Balance at June 30, 2022 | 577.8 | 2393.6 | 25.3 | (975.0) | (16.6) | 4575.9 | 5977.9 |
| Net Income |  |  |  |  |  | 546.2 | 546.2 |
| Other comprehensive income |  |  |  |  | 5.0 |  | 5.0 |
| Proceeds from sales of common stock through employee equity incentive plans | 1.4 | 24.4 |  |  |  |  | 24.4 |
| RSU and SAR withholdings | (0.3) | (20.7) |  |  |  |  | (20.7) |
| Treasury stock used for new issuances | (1.1) | (24.8) | (1.1) | 24.8 |  |  |  |
| Repurchase of common stock |  |  | 3.6 | (247.2) |  |  | (247.2) |
| Settlement of convertible debt |  | (58.2) |  |  |  |  | (58.2) |
| Share-based compensation |  | 41.8 |  |  |  |  | 41.8 |
| Cash dividend |  |  |  |  |  | (166.1) | (166.1) |
| Balance at September 30, 2022 | 577.8 | 2356.1 | 27.8 | (1197.4) | (11.6) | 4956.0 | 6103.1 |
| Net income |  |  |  |  |  | 580.3 | 580.3 |
| Other comprehensive loss |  |  |  |  | (5.9) |  | (5.9) |
| Proceeds from sales of common stock through employee equity incentive plans | 1.1 | 16.5 |  |  |  |  | 16.5 |
| RSU and SAR withholdings | (0.2) | (17.1) |  |  |  |  | (17.1) |
| Treasury stock used for new issuances | (0.9) | (19.1) | (0.9) | 19.1 |  |  |  |
| Repurchase of common stock |  |  | 3.1 | (229.5) |  |  | (229.5) |
| Share-based compensation |  | 44.5 |  |  |  |  | 44.5 |
| Cash dividend |  |  |  |  |  | (180.3) | (180.3) |
| Balance at December 31, 2022 | 577.8 | $2380.9 | 30.0 | $(1407.8) | $(17.5) | $5356.0 | $6311.6 |

---

See accompanying notes to condensed consolidated financial statements

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES**

**Notes to Condensed Consolidated Financial Statements** 

**Note 1. Basis of Presentation** 

The accompanying unaudited condensed consolidated financial statements include the accounts of Microchip Technology Incorporated and its majority-owned and controlled subsidiaries (the Company). All significant intercompany accounts and transactions have been eliminated in consolidation. All dollar amounts in the financial statements and tables in these notes, except per share amounts, are stated in millions of U.S. dollars unless otherwise noted.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP, pursuant to the rules and regulations of the SEC. The information furnished herein reflects all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the interim periods reported. Certain information and footnote disclosures normally included in audited consolidated financial statements have been condensed or omitted pursuant to such SEC rules and regulations. It is suggested that these condensed consolidated financial statements be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022. The results of operations for the three and nine months ended December 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2023 or for any other period.

**Note 2. Recently Issued Accounting Pronouncements** 

***Recently Adopted Accounting Pronouncements***

On April 1, 2022, the Company adopted ASU 2020-06-*Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity,* which simplifies the guidance for certain convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature or convertible instruments with a beneficial conversion feature. As a result, convertible debt instruments are reported as a single liability instrument with no separate accounting for embedded conversion features. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will be no longer available. The Company adopted the standard under the modified retrospective transition method for fiscal 2023. The adoption of this standard resulted in an increase of $105.8 million to the Company's Convertible Debt, to reflect the full principal amount of the Convertible Debt outstanding net of issuance costs, a reduction to additional paid-in capital of $128.3 million, net of estimated income tax effects, to remove the equity component separately recorded for the conversion features associated with the Convertible Debt, a decrease to deferred tax liabilities, and a cumulative-effect adjustment of $46.5 million, net of estimated income tax effects, to increase the opening balance of retained earnings as of April 1, 2022. In addition, the required use of the if-converted method in calculating diluted earnings per share is not expected to increase the number of potentially dilutive shares in fiscal 2023 as the Company irrevocably elected cash settlement for the principal amount of its Convertible Debt on April 1, 2022.

***Recently Issued Accounting Pronouncements Not Yet Adopted***

In November 2021, the FASB issued ASU 2021-10-*Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance* which aims at increasing the transparency of government assistance received by most business entities. The standard requires business entities to make annual disclosures about the nature of the transactions and the related accounting policy used to account for the transactions, the line items and applicable amounts on the balance sheet and income statement that are affected by the transactions, and significant terms and conditions of the transactions, including commitments and contingencies. If an entity omits any required disclosures because it is legally prohibited, it must disclose that fact. ASU 2021-10 is effective for financial statements issued for annual periods beginning after December 15, 2021, and the Company is currently evaluating the applicable disclosures.

**Note 3. Segment Information** 

The Company's reportable segments are semiconductor products and technology licensing. The Company does not allocate operating expenses, interest income, interest expense, other income or expense, or provision for or benefit from income taxes to these segments for internal reporting purposes, as the Company does not believe that allocating these expenses is beneficial in evaluating segment performance. Additionally, the Company does not allocate assets to segments for internal reporting purposes as it does not manage its segments by such metrics.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

The following tables represent net sales and gross profit for each segment for the periods presented (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, 2022 | Three Months Ended December 31, 2022 | Nine Months Ended December 31, 2022 | Nine Months Ended December 31, 2022 |
| | Net Sales | Gross Profit | Net Sales | Gross Profit |
| Semiconductor products | $2124.8 | $1426.4 | $6078.7 | $4051.3 |
| Technology licensing | 44.4 | 44.4 | 127.3 | 127.3 |
| Total | $2169.2 | $1470.8 | $6206.0 | $4178.6 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, 2021 | Three Months Ended December 31, 2021 | Nine Months Ended December 31, 2021 | Nine Months Ended December 31, 2021 |
| | Net Sales | Gross Profit | Net Sales | Gross Profit |
| Semiconductor products | $1725.5 | $1121.3 | $4884.5 | $3137.0 |
| Technology licensing | 32.0 | 32.0 | 92.2 | 92.2 |
| Total | $1757.5 | $1153.3 | $4976.7 | $3229.2 |

---

**Note 4. Net Sales** 

The following table represents the Company's net sales by product line (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Microcontrollers | $1221.3 | $972.2 | $3463.8 | $2768.7 |
| Analog | 606.5 | 500.5 | 1759.0 | 1423.5 |
| Other | 341.4 | 284.8 | 983.2 | 784.5 |
| Total net sales | $2169.2 | $1757.5 | $6206.0 | $4976.7 |

---

The product lines listed above are included entirely in the Company's semiconductor product segment with the exception of the other product line, which includes products from both the semiconductor product and technology licensing segments.

The following table represents the Company's net sales by customer type (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Distributors | $1032.3 | $787.1 | $2903.7 | $2387.2 |
| Direct customers | 1092.5 | 938.4 | 3175.0 | 2497.3 |
| Licensees | 44.4 | 32.0 | 127.3 | 92.2 |
| Total net sales | $2169.2 | $1757.5 | $6206.0 | $4976.7 |

---

Distributors are customers that buy products with the intention of reselling them. Distributors generally have a distributor agreement with the Company to govern the terms of the relationship. Direct customers are non-distributor customers, which generally do not have a master sales agreement with the Company. The Company's direct customers primarily consist of OEMs and, to a lesser extent, contract manufacturers. Licensees are customers of the Company's technology licensing segment, which include purchasers of intellectual property and customers that have licensing agreements to use the Company's SuperFlash® embedded flash technology. All of the customer types listed in the table above are included in the Company's semiconductor product segment with the exception of licenses, which is included in the technology licensing segment.

The Company collects amounts in advance for certain of its contracts with customers. These amounts are deferred until control of the product or service is transferred to the customer at which time it is recognized as revenue. As of December 31, 2022, the Company had approximately $673.3 million of deferred revenue in the semiconductor product segment, of which $111.2 million is included within accrued liabilities and the remaining is included within other long-term liabilities on the Company's condensed consolidated balance sheet. As of March 31, 2022, the Company had approximately $117.6 million of deferred revenue in the semiconductor product segment, of which $73.2 million is included within accrued liabilities and the remaining is included within other long-term liabilities on the Company's condensed consolidated balance sheet. Deferred revenue represents amounts that have been invoiced in advance which are expected to be recognized as revenue in future periods.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

Of the $673.3 million of deferred revenue as of December 31, 2022, $585.7 million is cash collected from customers under long-term supply agreements (LTSA's) of which $27.7 million is included within accrued liabilities and $558.0 million is included within other long-term liabilities. Under these LTSA's, the Company receives an upfront deposit from the customer in exchange for assured supply over the contract period, which typically ranges from three to five years. If the customer does not meet the minimum purchase commitments defined in the contract, the Company may retain all, or portions of, the deposit as revenue. The remaining performance obligations for the LTSA's were approximately $4 billion as of December 31, 2022, of which approximately 10% is expected to be recognized as net sales during the next 12 months. The amount and timing of such net sales is uncertain because it depends on the satisfaction of commitments made in the LTSA's, which may be affected by the timing and amount of orders placed by customers, contract modifications, variable consideration, sales channels, and manufacturing and supply chain challenges. The remaining $87.6 million of deferred revenue as of December 31, 2022 is related to other cash payments received from customers in advance of the Company's performance obligations being satisfied. Nearly all the $87.6 million will be recognized as net sales within the next 12 months.

In addition to the LTSA's, a portion of the Company's non-LTSA customer contracts contain firmly committed orders beyond 12 months at the time of order. The transaction price for these orders with remaining performance obligations as of December 31, 2022 for orders with initial durations in excess of 12 months approximates 80% of fiscal 2022 net sales and does not include estimates of variable consideration. Approximately 80% of which is expected to be recognized over the next 12 months. The amount and timing of such net sales is inherently uncertain because the ultimate transaction prices will be affected by variable consideration which is subject to change based upon market conditions at the time of the sale, contract modifications, and manufacturing and supply chain challenges. Accordingly, the amount may not be indicative of net sales in future periods.

**Note 5. Net Income Per Common Share** 

The following table sets forth the computation of basic and diluted net income per common share (in millions, except per share amounts):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Net income | $580.3 | $352.8 | $1633.7 | $847.6 |
| Basic weighted average common shares outstanding | 549.2 | 554.9 | 551.5 | 551.2 |
| Dilutive effect of stock options and RSUs | 4.8 | 7.0 | 5.1 | 7.4 |
| Dilutive effect of 2015 Senior Convertible Debt | 0.4 | 2.0 | 0.7 | 3.1 |
| Dilutive effect of 2017 Senior Convertible Debt | 0.9 | 3.0 | 1.0 | 3.4 |
| Dilutive effect of 2017 Junior Convertible Debt | 0.1 | 0.4 | 0.1 | 1.0 |
| Diluted weighted average common shares outstanding | 555.4 | 567.3 | 558.4 | 566.1 |
| Basic net income per common share | $1.06 | $0.64 | $2.96 | $1.54 |
| Diluted net income per common share | $1.04 | $0.62 | $2.93 | $1.50 |

---

The Company computed basic net income per common share based on the weighted average number of common shares outstanding during the period. The Company computed diluted net income per common share based on the weighted average number of common shares outstanding plus potentially dilutive common shares outstanding during the period.

Potentially dilutive common shares from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options and the assumed vesting of outstanding RSUs. Prior to conversion of its Convertible Debt, the Company will include, in the diluted net income per common share calculation, the effect of the additional shares that may be issued when the Company's common stock price exceeds the conversion price using the if-converted method beginning April 1, 2022 due to the adoption of ASU 2020-06 (see Note 2 for details on adoption of ASU 2020-06). The Company's Convertible Debt has no impact on diluted net income per common share unless the average price of the Company's common stock exceeds the conversion price because the Company is required to settle the principal amount of the Convertible Debt in cash upon conversion.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

The following is the weighted average conversion price per share used in calculating the dilutive effect (see Note 7 for details on the Convertible Debt):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| 2015 Senior Convertible Debt | $29.52 | $30.05 | $29.65 | $30.14 |
| 2017 Senior Convertible Debt | $46.03 | $46.86 | $46.23 | $47.00 |
| 2020 Senior Convertible Debt | $92.74 | $93.32 | $92.91 | $93.37 |
| 2017 Junior Convertible Debt | $45.22 | $46.04 | $45.42 | $46.17 |

---

**Note 6. Special Charges (Income) and Other, Net** 

During the three and nine months ended December 31, 2022, the Company incurred special charges and other, net of $6.5 million and earned special income and other, net of $6.1 million, respectively. The special charges and other, net incurred during the three months ended December 31, 2022, primarily related to restructuring of acquired and existing wafer fabrication operations to increase operational efficiency. The special income and other, net earned during the nine months ended December 31, 2022, primarily related to a favorable resolution of a previously accrued legal matter offset by restructuring costs of acquired and existing wafer fabrication operations to increase operational efficiency. During the three and nine months ended December 31, 2021, the Company earned special income and other, net of $0.3 million and incurred special charges and other, net of $20.4 million, respectively. The special income and other, net earned during the three months ended December 31, 2021, and the special charges and other, net incurred during the nine months ended December 31, 2021, primarily related to restructuring of acquired and existing wafer fabrication operations to increase operational efficiency, legal contingencies and exiting non-manufacturing facilities including contract termination costs, employee severance, and the disposal of assets.

**Note 7. Debt** 

Debt obligations included in the condensed consolidated balance sheets consisted of the following (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Coupon Interest Rate | Effective Interest Rate | | |
| | Coupon Interest Rate | Effective Interest Rate | December 31, 2022 | March 31, 2022 |
| | Coupon Interest Rate | Effective Interest Rate | December 31, 2022 | March 31, 2022 |
| Revolving Credit Facility |  |  | $253.0 | $1399.1 |
| 4.333% 2023 Notes | 4.333% | 4.7% | 1000.0 | 1000.0 |
| 2.670% 2023 Notes | 2.670% | 2.8% | 1000.0 | 1000.0 |
| 0.972% 2024 Notes | 0.972% | 1.1% | 1400.0 | 1400.0 |
| 0.983% 2024 Notes | 0.983% | 1.1% | 1000.0 | 1000.0 |
| 4.250% 2025 Notes | 4.250% | 4.6% | 1200.0 | 1200.0 |
| Total Senior Indebtedness |  |  | 5853.0 | 6999.1 |
| *Senior Subordinated Convertible Debt - Principal Outstanding* | *Senior Subordinated Convertible Debt - Principal Outstanding* | *Senior Subordinated Convertible Debt - Principal Outstanding* |  |  |
| 2015 Senior Convertible Debt | 1.625% | 1.8% | 12.4 | 34.4 |
| 2017 Senior Convertible Debt | 1.625% | 1.8% | 82.2 | 128.1 |
| 2020 Senior Convertible Debt | 0.125% | 0.5% | 665.5 | 665.5 |
| *Junior Subordinated Convertible Debt - Principal Outstanding* | *Junior Subordinated Convertible Debt - Principal Outstanding* | *Junior Subordinated Convertible Debt - Principal Outstanding* |  |  |
| 2017 Junior Convertible Debt | 2.250% | 2.3% | 6.5 | 10.1 |
| Total Convertible Debt |  |  | 766.6 | 838.1 |
| Gross long-term debt including current maturities |  |  | 6619.6 | 7837.2 |
| Less: Debt discount<sup>(1)</sup> |  |  | (12.3) | (124.6) |
| Less: Debt issuance costs<sup>(2)</sup> |  |  | (18.6) | (25.2) |
| Net long-term debt including current maturities |  |  | 6588.7 | 7687.4 |
| Less: Current maturities<sup>(3)</sup> |  |  |  |  |
| Net long-term debt |  |  | $6588.7 | $7687.4 |

---

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>(1)</sup> The unamortized discount consists of the following (in millions): 

---

| | | |
|:---|:---|:---|
| | December 31,<br>2022 | March 31,<br>2022 |
| 4.333% 2023 Notes | $(0.5) | $(1.3) |
| 2.670% 2023 Notes | (0.6) | (1.3) |
| 0.972% 2024 Notes | (1.5) | (2.5) |
| 0.983% 2024 Notes | (1.6) | (2.2) |
| 4.250% 2025 Notes | (8.1) | (10.2) |
| 2015 Senior Convertible Debt |  | (3.7) |
| 2017 Senior Convertible Debt |  | (23.4) |
| 2020 Senior Convertible Debt |  | (75.3) |
| 2017 Junior Convertible Debt |  | (4.7) |
| Total unamortized discount | $(12.3) | $(124.6) |

---

As of April 1, 2022, the unamortized debt discount of the Convertible Debt was eliminated upon the Company's adoption of ASU 2020-06 (see Note 2 for further information).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(2)</sup> Debt issuance costs consist of the following (in millions):

---

| | | |
|:---|:---|:---|
| | December 31,<br>2022 | March 31,<br>2022 |
| Revolving Credit Facility | $(8.9) | $(10.6) |
| 4.333% 2023 Notes | (1.0) | (2.9) |
| 2.670% 2023 Notes | (0.4) | (0.8) |
| 0.972% 2024 Notes | (0.7) | (1.3) |
| 0.983% 2024 Notes | (0.9) | (1.4) |
| 4.250% 2025 Notes | (1.0) | (1.3) |
| 2015 Senior Convertible Debt | (0.1) | (0.1) |
| 2017 Senior Convertible Debt | (0.4) | (0.6) |
| 2020 Senior Convertible Debt | (5.1) | (6.2) |
| 2017 Junior Convertible Debt | (0.1) |  |
| Total debt issuance costs | $(18.6) | $(25.2) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(3)</sup> As of December 31, 2022, the 2.670% 2023 Notes, which mature on September 1, 2023, and the 4.333% 2023 Notes, which mature on June 1, 2023, are excluded from current maturities as the Company has the intent and ability to utilize proceeds from its Revolving Credit Facility to refinance such notes on a long-term basis. As of December 31, 2022, and March 31, 2022, the 2015 Senior Convertible Debt, the 2017 Senior Convertible Debt and the 2017 Junior Convertible Debt were convertible and are excluded from current maturities as the Company has the intent and ability to utilize proceeds from its Revolving Credit Facility to settle the principal portion of its Convertible Debt upon conversion.

Expected maturities relating to the Company's debt obligations as of December 31, 2022, are as follows (in millions):

---

| | |
|:---|:---|
| Fiscal year ending March 31, | Amount |
| 2023 | $— |
| 2024 | 3400.0 |
| 2025 | 1677.9 |
| 2026 | 1200.0 |
| 2027 | 335.2 |
| Thereafter | 6.5 |
| Total | $6619.6 |

---

*Ranking of Convertible Debt* - Each series of Convertible Debt is an unsecured obligation which is subordinated in right of payment to the amounts outstanding under the Company's Senior Indebtedness. The 2017 Junior Convertible Debt is expressly subordinated in right of payment to any existing and future senior debt of the Company (including the Senior Indebtedness and the Senior Subordinated Convertible Debt) and is structurally subordinated in right of payment to the liabilities of the Company's subsidiaries. The Senior Subordinated Convertible Debt is subordinated to the Senior

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

Indebtedness; ranks senior to the Company's indebtedness that is expressly subordinated in right of payment to it, including the 2017 Junior Convertible Debt; ranks equal in right of payment to any of the Company's unsubordinated indebtedness that does not provide that it is senior to the Senior Subordinated Convertible Debt; ranks junior in right of payment to any of the Company's secured and unsecured unsubordinated indebtedness to the extent of the value of the assets securing such indebtedness; and is structurally subordinated to all indebtedness and other liabilities of the Company's subsidiaries.

*Summary of Conversion Features* - Each series of Convertible Debt is convertible, subject to certain conditions, into cash, shares of the Company's common stock or a combination thereof, at the Company's election, at specified conversion rates (see table below), adjusted for certain events including the declaration of cash dividends. Except during the three-month period immediately preceding the maturity date of the applicable series of Convertible Debt, each series of Convertible Debt is convertible only upon the occurrence of (i) such time as the closing price of the Company's common stock exceeds the applicable conversion price (see table below) by 130% for 20 days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding fiscal quarter, (ii) during the 5 business day period after any 10 consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of notes of a given series for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company's common stock and the applicable conversion rate on each such trading day or (iii) upon the occurrence of certain corporate events specified in the indenture of such series of Convertible Debt. In addition, for each series, with the exception of the 2020 Senior Convertible Debt, if at the time of conversion the applicable price of the Company's common stock exceeds the applicable conversion price at such time, the applicable conversion rate will be increased by up to an additional maximum incremental shares rate, as determined pursuant to a formula specified in the indenture for the applicable series of Convertible Debt, and as adjusted for cash dividends paid since the issuance of such series of Convertible Debt. However, in no event will the applicable conversion rate exceed the applicable maximum conversion rate specified in the indenture for the applicable series of Convertible Debt (see table below). On April 1, 2022, the Company irrevocably elected cash settlement for the principal amount of its Convertible Debt. See Note 2 for further information.

The following table sets forth the applicable conversion rates adjusted for dividends declared since issuance of such series of Convertible Debt and the applicable incremental share factors and maximum conversion rates as adjusted for dividends paid since the applicable issuance date:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Dividend adjusted rates as of December 31, 2022 | Dividend adjusted rates as of December 31, 2022 | Dividend adjusted rates as of December 31, 2022 | Dividend adjusted rates as of December 31, 2022 |
| | Conversion Rate | Approximate Conversion Price | Incremental Share Factor | Maximum Conversion Rate |
| 2015 Senior Convertible Debt<sup>(1)</sup> | 33.8782 | $29.52 | 16.9408 | 47.4285 |
| 2017 Senior Convertible Debt<sup>(1)</sup> | 21.7240 | $46.03 | 10.8627 | 30.9569 |
| 2020 Senior Convertible Debt<sup>(1)</sup> | 10.7826 | $92.74 |  | 15.0956 |
| 2017 Junior Convertible Debt<sup>(1)</sup> | 22.1122 | $45.22 | 11.0572 | 30.9569 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> As of December 31, 2022, the 2020 Senior Convertible Debt was not convertible. As of December 31, 2022, the holders of each of the 2015 Senior Convertible Debt, 2017 Senior Convertible Debt, and 2017 Junior Convertible Debt have the right to convert their notes between January 1, 2023 and March 31, 2023 because the Company's common stock price has exceeded the applicable conversion price for such series by 130% for the specified period of time during the quarter ended December 31, 2022. As of December 31, 2022, the adjusted conversion rate for the 2015 Senior Convertible Debt, 2017 Senior Convertible Debt, and 2017 Junior Convertible Debt would be increased to 43.7008 shares of common stock, 25.4688 shares of common stock, and 26.0513 shares of common stock, respectively, per $1,000 principal amount of notes based on the closing price of $70.25 per share of common stock to include an additional maximum incremental share rate per the terms of the applicable indenture. As of December 31, 2022, each of the 2015 Senior Convertible Debt, 2017 Senior Convertible Debt, and 2017 Junior Convertible Debt had a conversion value in excess of par of $25.7 million, $64.9 million, and $5.4 million, respectively.

With the exception of the 2020 Senior Convertible Debt, which became redeemable by the Company after November 20, 2022, the Company may not redeem any series of Convertible Debt prior to the relevant maturity date and no sinking fund is provided for any series of Convertible Debt. Under the terms of the applicable indenture, the Company may repurchase any series of Convertible Debt in the open market or through privately negotiated exchange offers. Upon the occurrence of a fundamental change, as defined in the applicable indenture of such series of Convertible Debt, holders of such series may require the Company to purchase all or a portion of their Convertible Debt for cash at a price equal to 100% of the principal amount plus any accrued and unpaid interest.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

Interest expense consists of the following (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Debt issuance cost amortization | $1.7 | $2.2 | $5.1 | $7.4 |
| Debt discount amortization | 1.8 | 1.7 | 5.4 | 5.3 |
| Interest expense | 46.8 | 45.3 | 137.8 | 144.9 |
| Total interest expense on Senior Indebtedness | 50.3 | 49.2 | 148.3 | 157.6 |
| Debt issuance cost amortization | 0.7 | 0.6 | 2.0 | 1.8 |
| Debt discount amortization |  | 9.0 |  | 29.6 |
| Coupon interest expense | 0.6 | 1.5 | 2.3 | 6.5 |
| Total interest expense on Convertible Debt | 1.3 | 11.1 | 4.3 | 37.9 |
| Other interest expense | 1.2 | 1.8 | 3.8 | 3.7 |
| Total interest expense | $52.8 | $62.1 | $156.4 | $199.2 |

---

The Company's debt settlement transactions consists of the following (in millions)<sup>(1)</sup>:

---

| | | | |
|:---|:---|:---|:---|
| | Principal Amount Settled | Total Cash Consideration | Net Loss on Inducements and Settlements |
| | Principal Amount Settled | Total Cash Consideration | Net Loss on Inducements and Settlements |
| *August 2022* |  |  |  |
| 2015 Senior Convertible Debt | $22.0 | $67.7 | $1.3 |
| 2017 Senior Convertible Debt | $14.9 | $29.2 | $0.8 |
| *May 2022* |  |  |  |
| 2017 Senior Convertible Debt | $31.0 | $65.3 | $5.9 |
| 2017 Junior Convertible Debt | $3.6 | $8.2 | $0.3 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> The Company settled portions of its convertible debt in privately negotiated transactions that are accounted for as induced conversions.

**Note 8. Fair Value of Financial Instruments** 

Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company utilizes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level 1-Observable inputs such as quoted prices in active markets;

Level 2-Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

Level 3-Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

The carrying amount of cash equivalents approximates fair value because their maturity is less than three months. Management believes the carrying amount of the equity investments materially approximated fair value at December 31, 2022 based upon unobservable inputs. The fair values of these investments have been determined as Level 3 fair value measurements. The carrying amount of accounts receivable, accounts payable and accrued liabilities approximates fair value due to the short-term maturity of the amounts and are considered Level 2 in the fair value hierarchy.

The fair value of the Company's Revolving Credit Facility is estimated using discounted cash flow analysis, based on the Company's current incremental borrowing rates for similar types of borrowing arrangements. Based on the borrowing rates currently available to the Company for bank loans with similar terms and average maturities, the fair value of the Company's Revolving Credit Facility at December 31, 2022 approximated the carrying value excluding debt discounts and debt issuance costs and are considered Level 2 in the fair value hierarchy. The Company measures the fair value of its Convertible Debt and

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

Senior Notes for disclosure purposes. These fair values are based on observable market prices for this debt, which is traded in less active markets and are therefore classified as a Level 2 fair value measurement.

The following table shows the carrying amounts and fair values of the Company's debt obligations (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | December 31, 2022 | December 31, 2022 | March 31, 2022 | March 31, 2022 |
| | Carrying Amount<sup>(1)</sup> | Fair Value | Carrying Amount<sup>(1)</sup> | Fair Value |
| Revolving Credit Facility | $244.1 | $253.0 | $1388.5 | $1399.1 |
| 4.333% 2023 Notes | 998.5 | 995.5 | 995.8 | 1017.1 |
| 2.670% 2023 Notes | 999.0 | 982.4 | 997.9 | 997.7 |
| 0.972% 2024 Notes | 1397.8 | 1331.7 | 1396.2 | 1343.9 |
| 0.983% 2024 Notes | 997.5 | 928.3 | 996.4 | 946.3 |
| 4.250% 2025 Notes | 1190.9 | 1158.0 | 1188.5 | 1213.6 |
| 2015 Senior Convertible Debt | 12.3 | 39.3 | 30.6 | 115.4 |
| 2017 Senior Convertible Debt | 81.8 | 164.3 | 104.1 | 285.6 |
| 2020 Senior Convertible Debt | 660.4 | 700.6 | 584.0 | 765.5 |
| 2017 Junior Convertible Debt | 6.4 | 12.8 | 5.4 | 21.7 |
| Total | $6588.7 | $6565.9 | $7687.4 | $8105.9 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> The carrying amounts presented are net of debt discounts and debt issuance costs (see Note 7 for further information).

**Note 9. Intangible Assets and Goodwill** 

Intangible assets consist of the following (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | December 31, 2022 | December 31, 2022 | December 31, 2022 |
| | Gross Amount | Accumulated Amortization | Net Amount |
| Core and developed technology | $7421.3 | $(4070.4) | $3350.9 |
| Customer-related | 199.8 | (123.9) | 75.9 |
| In-process research and development | 5.7 |  | 5.7 |
| Software licenses | 210.6 | (98.3) | 112.3 |
| Distribution rights and other | 0.3 | (0.3) |  |
| Total | $7837.7 | $(4292.9) | $3544.8 |

---

---

| | | | |
|:---|:---|:---|:---|
| | March 31, 2022 | March 31, 2022 | March 31, 2022 |
| | Gross Amount | Accumulated Amortization | Net Amount |
| Core and developed technology | $7390.2 | $(3571.5) | $3818.7 |
| Customer-related | 200.3 | (112.4) | 87.9 |
| In-process research and development | 6.4 |  | 6.4 |
| Software licenses | 191.2 | (61.2) | 130.0 |
| Distribution rights and other | 0.4 | (0.3) | 0.1 |
| Total | $7788.5 | $(3745.4) | $4043.1 |

---

The following is an expected amortization schedule for the intangible assets for the remainder of fiscal 2023 through fiscal 2027, absent any future acquisitions or impairment charges (in millions):

---

| | |
|:---|:---|
| Fiscal Year Ending March 31, | Amortization Expense |
| 2023 | $187.5 |
| 2024 | $675.1 |
| 2025 | $541.7 |
| 2026 | $469.4 |
| 2027 | $380.0 |

---

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

The Company amortizes intangible assets over their expected useful lives, which range between 1 and 15 years. Amortization expense attributed to intangible assets are assigned to cost of sales and operating expenses as follows (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Amortization expense charged to cost of sales | $4.3 | $3.2 | $11.5 | $9.1 |
| Amortization expense charged to operating expense | 184.4 | 232.5 | 553.1 | 691.4 |
| Total amortization expense | $188.7 | $235.7 | $564.6 | $700.5 |

---

The Company recognized impairment charges of $1.4 million in the three and nine months ended December 31, 2022. There were no impairment charges in the three and nine months ended December 31, 2021.

The following shows the goodwill balance as of December 31, 2022, and March 31, 2022 by segment (in millions):

---

| | | |
|:---|:---|:---|
| | Semiconductor Products Reporting Unit | Technology Licensing Reporting Unit |
| Goodwill | $6654.4 | $19.2 |

---

At March 31, 2022, the Company applied a qualitative goodwill impairment test to its two reporting units, concluding it was not more likely than not that goodwill was impaired. Through December 31, 2022, the Company has never recorded a goodwill impairment charge.

**Note 10. Other Financial Statement Details** 

**Accounts Receivable**

Accounts receivable consists of the following (in millions):

---

| | | |
|:---|:---|:---|
| | December 31,<br>2022 | March 31,<br>2022 |
| Trade accounts receivable | $1169.7 | $1069.5 |
| Other | 12.9 | 9.3 |
| Total accounts receivable, gross | 1182.6 | 1078.8 |
| Less: allowance for expected credit losses | 7.6 | 6.2 |
| Total accounts receivable, net | $1175.0 | $1072.6 |

---

The Company sells certain of its trade accounts receivable on a non-recourse basis to a third-party financial institution pursuant to a factoring arrangement. The Company accounts for these transactions as sales of receivables and presents cash proceeds as cash provided by operating activities in the consolidated statements of cash flows. Total trade accounts receivable sold under the factoring arrangement were $208.9 million and $563.8 million for the three and nine months ended December 31, 2022, respectively, compared to $129.4 million and $346.6 million for the three and nine months ended December 31, 2021, respectively. Factoring fees for the sales of receivables were recorded in other income, net and were not material for any of the periods presented. After the sale of its trade accounts receivable, the Company will collect payment from the customer and remit it to the third-party financial institution. The amount of trade accounts receivable sold for which cash has not been collected from the customer is immaterial as of December 31, 2022, and 2021.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Inventories**

The components of inventories consist of the following (in millions):

---

| | | |
|:---|:---|:---|
| | December 31,<br>2022 | March 31,<br>2022 |
| Raw materials | $207.3 | $163.0 |
| Work in process | 679.4 | 482.8 |
| Finished goods | 278.7 | 208.6 |
| Total inventories | $1165.4 | $854.4 |

---

**Property, Plant and Equipment**

Property, plant and equipment consists of the following (in millions):

---

| | | |
|:---|:---|:---|
| | December 31,<br>2022 | March 31,<br>2022 |
| Land | $88.2 | $88.2 |
| Building and building improvements | 714.1 | 674.4 |
| Machinery and equipment | 2624.7 | 2471.6 |
| Projects in process | 293.4 | 182.4 |
| Total property, plant and equipment, gross | 3720.4 | 3416.6 |
| Less: accumulated depreciation and amortization | 2606.7 | 2448.7 |
| Total property, plant and equipment, net | $1113.7 | $967.9 |

---

Depreciation expense attributed to property, plant and equipment was $55.3 million and $190.6 million for the three and nine months ended December 31, 2022, respectively, compared to $64.9 million and $149.8 million for the three and nine months ended December 31, 2021, respectively. The increase in depreciation expense in the nine months ended December 31, 2022, includes the impact of current production levels, manufacturing expansion activities and moving and repurposing floor space and equipment.

The Company reviews and evaluates its long-lived assets for impairment when events or changes in circumstances indicate that the related carrying amount of such assets may not be recoverable. For each of the three and nine months ended December 31, 2022, and 2021 the Company's evaluation of its property, plant and equipment did not result in any material impairments.

**Accrued Liabilities**

Accrued liabilities consists of the following (in millions):

---

| | | |
|:---|:---|:---|
| | December 31,<br>2022 | March 31,<br>2022 |
| Accrued compensation and benefits | $212.4 | $213.7 |
| Income taxes payable | 109.9 | 121.5 |
| Sales related reserves | 552.2 | 408.1 |
| Current portion of lease liabilities | 33.7 | 33.8 |
| Accrued expenses and other liabilities | 348.1 | 277.2 |
| Total accrued liabilities | $1256.3 | $1054.3 |

---

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Note 11. Commitments and Contingencies** 

*Purchase Commitments*

The Company's purchase commitments primarily consist of agreements for the purchase of property, plant and equipment and other goods and services including wafer purchase obligations with the Company's wafer foundries, and manufacturing supply capacity reservation commitments.

Total purchase commitments as of December 31, 2022, are as follows (in millions):

---

| | |
|:---|:---|
| Fiscal Year Ending March 31, | Purchase Commitments |
| 2023 | $627.2 |
| 2024 | 476.8 |
| 2025 | 131.0 |
| 2026 | 108.1 |
| 2027 | 96.9 |
| Thereafter | 334.1 |
| Total | $1774.1 |

---

*Indemnification Contingencies*

The Company's technology license agreements generally include an indemnification clause that indemnifies the licensee against liability and damages (including legal defense costs) arising from any claims of patent, copyright, trademark or trade secret infringement by the Company's proprietary technology. The terms of these indemnification provisions approximate the terms of the outgoing technology license agreements, which are typically perpetual unless terminated by either party for breach. The possible amount of future payments the Company could be required to make based on agreements that specify indemnification limits, if such indemnifications were required on all of these agreements, is approximately $179.0 million. There are some licensing agreements in place that do not specify indemnification limits. As of December 31, 2022, the Company had not recorded any liabilities related to these indemnification obligations and the Company believes that any amounts that it may be required to pay under these agreements in the future will not have a material adverse effect on its financial position, cash flows or results of operations.

*Warranty Costs and Product Liabilities*

The Company accrues for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, the Company has experienced a low rate of payments on product claims. Although the Company cannot predict the likelihood or amount of any future claims, the Company does not believe these claims will have a material adverse effect on its financial condition, results of operations or liquidity.

*Legal Matters*

In the ordinary course of the Company's business, it is exposed to various liabilities as a result of contracts, product liability, customer claims, governmental investigations and other matters. Additionally, the Company is involved in a limited number of legal actions, both as plaintiff and defendant. Consequently, the Company could incur uninsured liability in any of those actions. The Company also periodically receives notifications from various third parties alleging infringement of patents or other intellectual property rights, or from customers requesting reimbursement for various costs. With respect to pending legal actions to which the Company is a party and other claims, although the outcomes are generally not determinable, the Company believes that the ultimate resolution of these matters will not have a material adverse effect on its financial position, cash flows or results of operations. Litigation, governmental investigations and disputes relating to the semiconductor industry are not uncommon, and the Company is, from time to time, subject to such litigation, governmental investigations and disputes. As a result, no assurances can be given with respect to the extent or outcome of any such litigation, governmental investigations or disputes in the future.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

In connection with its acquisition of Microsemi, which closed on May 29, 2018, the Company became involved with the following legal matters:

*Derivative Litigation.* On January 22, 2019, a shareholder derivative lawsuit was filed against certain of the Company's officers and directors in the Superior Court of Arizona for Maricopa County, captioned *Reid v. Sanghi*, et al., Case No. CV2019-002389. The Company is named as a nominal defendant. The complaint generally alleges that defendants breached their fiduciary duties by, among other things, purportedly failing to conduct adequate due diligence regarding Microsemi prior to its acquisition, misrepresenting the Company's business prospects and health, and engaging in improper practices, and further alleges that certain defendants engaged in insider trading. The complaint asserts causes of action for breach of fiduciary duty, waste, and unjust enrichment and seeks unspecified monetary damages, corporate governance reforms, equitable and/or injunctive relief, restitution, and attorneys' fees and costs. An amended complaint was filed on February 28, 2020, and a second amended complaint was filed on July 27, 2020. The Company's Audit Committee filed a motion to dismiss. On April 4, 2022, the Court entered an order denying the Audit Committee's motion to dismiss. The case is proceeding. A trial setting conference is set for September 29, 2023. On August 5, 2021, a second shareholder derivative lawsuit was filed against certain of the Company's officers and directors in the Superior Court of Arizona for Maricopa County, captioned *Dutrisac v. Sanghi*, et al., Case No. CV2021-012459. The Company is named as a nominal defendant. The complaint asserts substantially the same allegations as those in the *Reid* case. The complaint asserts causes of action for breaches of fiduciary duty, insider selling, unjust enrichment, waste of corporate assets, indemnification, and contribution and seeks unspecified monetary damages, equitable and/or injunctive relief, disgorgement, corporate governance reforms, and attorneys' fees and costs. The Company's Audit Committee filed a motion to dismiss. On April 7, 2022, the Court entered an order denying the Audit Committee's motion to dismiss. The case is proceeding. A trial setting conference is set for September 29, 2023.

As a result of its acquisition of Atmel, which closed April 4, 2016, the Company became involved with the following legal matters:

*Continental Claim ICC Arbitration.* On December 29, 2016, Continental Automotive GmbH (Continental) filed a Request for Arbitration with the ICC, naming as respondents the Company's subsidiaries Atmel Corporation, Atmel SARL, Atmel Global Sales Ltd., and Atmel Automotive GmbH (collectively, Atmel). The Request alleges that a quality issue affecting Continental airbag control units in certain recalled vehicles stems from allegedly defective Atmel application specific integrated circuits (ASICs). Continental sought to recover from Atmel all current and future costs and damages incurred as a result of the vehicle manufacturers' airbag control unit-related recalls, with current costs and damages alleged to be approximately $77.0 million to date. The arbitral tribunal issued its decision on July 26, 2022, awarding Continental approximately $40.0 million in current damages and interest, and allowing Continental to recover future recall costs under certain conditions. We are unable to predict the amount of the future recall costs but do not expect such amount to be material.

*Individual Labor Actions by former LFR Employees*. In June 2010, Atmel Rousset sold its wafer manufacturing business in Rousset, France to LFoundry GmbH (LF), the German parent of LFoundry Rousset (LFR). LFR then leased the Atmel Rousset facility to conduct the manufacture of wafers. More than three years later, LFR became insolvent and later liquidated. In the wake of LFR's insolvency and liquidation, over 500 former employees of LFR filed individual labor actions against Atmel Rousset in a French labor court, and in 2019 a French labor court dismissed all of the employees' claims against Atmel Rousset. In 2020, the Plaintiffs filed appeals with the Court of Appeals requesting reconsideration of the earlier dismissals. In December 2022, the Court of Appeals dismissed these appeals and held that there had been no co-employment of the plaintiffs by Atmel Rousset and LFoundry Rousset. However, in 2017 these same claims were filed by this same group of employees in a regional court in France against Microchip Technology Incorporated and Atmel Corporation. The Company, and the other defendant entities, believe that each of these actions is entirely devoid of merit, and, further, that any assertion by any of the Claimants of a co-employment relationship with any of these entities is based substantially on the same specious arguments that the Paris Commercial Court summarily rejected in 2014 in related proceedings. The defendant entities therefore intend to defend vigorously against each of these claims. Additionally, complaints have been filed in a regional court in France on behalf of the same group of employees against Microchip Technology Rousset, Atmel Switzerland Sarl, Atmel Corporation and Microchip Technology Incorporated alleging that the sale of the Atmel Rousset production unit to LF was fraudulent and should be voided. These claims are specious and the defendant entities therefore intend to defend vigorously against these claims.

The Company accrues for claims and contingencies when losses become probable and reasonably estimable. As of the end of each applicable reporting period, the Company reviews each of its matters and, where it is probable that a liability has been or will be incurred, the Company accrues for all probable and reasonably estimable losses. Where the Company can reasonably estimate a range of losses it may incur regarding such a matter, the Company records an accrual for the amount

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

within the range that constitutes its best estimate. If the Company can reasonably estimate a range but no amount within the range appears to be a better estimate than any other, the Company uses the amount that is the low end of such range. As of December 31, 2022, the Company's estimate of the aggregate potential liability that is possible but not probable is approximately $100.0 million in excess of amounts accrued.

**Note 12. Income Taxes** 

The Company accounts for income taxes in accordance with ASC 740. The provision for income taxes is attributable to U.S. federal, state, and foreign income taxes. The Company's effective tax rate used for interim periods is based on an estimated annual effective tax rate including the tax effect of items required to be recorded discretely in the interim periods in which those items occur. The Company's effective tax rate for the nine months ended December 31, 2022, increased significantly over the same period last year primarily due to a provision in the TCJA. Research and development expenditures incurred by the Company after March 31, 2022, must be capitalized and amortized ratably over five or fifteen years for tax purposes, depending on the location in which the research activities are conducted. The resulting capitalization of research and development expenditures impacts the calculation of the Company's Global Intangible Low-Taxed Income (GILTI), which is treated as a period cost, beginning in the first quarter of fiscal 2023.

The Company's effective tax rate is different than the statutory rates in the U.S. due to foreign income taxed at different rates than the U.S., changes in uncertain tax benefit positions, changes to valuation allowances, generation of tax credits, and the impact of GILTI in the United States. In addition, the Company has numerous tax holidays it receives related to its Thailand manufacturing operations based on its investment in property, plant and equipment in Thailand. The Company's tax holiday periods in Thailand expire at various times in the future, however, the Company actively seeks to obtain new tax holidays. The material components of foreign income taxed at a rate lower than the U.S. are earnings accrued in Thailand, Malta, and Ireland.

The Company files U.S. federal, U.S. state, and foreign income tax returns. For U.S. federal, and in general for U.S. state tax returns, the fiscal 2007 and later tax years remain open for examination by tax authorities. For foreign tax returns, the Company is generally no longer subject to income tax examinations for years prior to fiscal 2007.

**Note 13. Share-Based Compensation** 

The following table presents the details of the Company's share-based compensation expense (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Cost of sales<sup>(1)</sup> | $6.9 | $8.4 | $21.1 | $26.3 |
| Research and development | 21.2 | 23.4 | 61.1 | 76.1 |
| Selling, general and administrative | 15.9 | 19.1 | 44.3 | 60.8 |
| Pre-tax effect of share-based compensation | 44.0 | 50.9 | 126.5 | 163.2 |
| Income tax benefit | 9.4 | 10.8 | 27.0 | 34.6 |
| Net income effect of share-based compensation | $34.6 | $40.1 | $99.5 | $128.6 |

---

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> During the three and nine months ended December 31, 2022, $5.0 million and $14.5 million, respectively, of share-based compensation expense was capitalized to inventory and $6.9 million and $21.1 million, respectively, of previously capitalized share-based compensation expense in inventory was sold. During the three and nine months ended December 31, 2021, $5.3 million and $16.4 million, respectively, of share-based compensation expense was capitalized to inventory and $8.4 million and $26.3 million, respectively, of previously capitalized share-based compensation expense in inventory was sold.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Note 14. Stock Repurchase Activity** 

In November 2021, the Company's Board of Directors approved a new stock repurchase program to repurchase up to $4.00 billion of the Company's common stock in the open market or in privately negotiated transactions. There is no expiration date associated with the repurchase program. During the three and nine months ended December 31, 2022 the Company purchased approximately 3.1 million shares and 9.6 million shares, respectively, of its common stock for a total of $229.5 million and $671.9 million, respectively, under the program. As of December 31, 2022 approximately $2.90 billion remained available for repurchases under the program. Shares repurchased are recorded as treasury shares and are used to fund share issuance requirements under the Company's equity incentive plans. As of December 31, 2022 the Company had approximately 30.0 million treasury shares.

**Note 15. Accumulated Other Comprehensive Loss** 

The following table presents the changes in the components of accumulated other comprehensive loss, net of tax (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | Minimum Pension Liability | Foreign Currency | Total |
| Balance at March 31, 2022 | $(5.6) | $(15.0) | $(20.6) |
| Other comprehensive income (loss) before reclassifications | 2.9 | (0.1) | 2.8 |
| Reclassification of realized transactions | 0.3 |  | 0.3 |
| Net other comprehensive income (loss) | 3.2 | (0.1) | 3.1 |
| Balance at December 31, 2022 | $(2.4) | $(15.1) | $(17.5) |

---

**Note 16. Dividends** 

A quarterly cash dividend of $0.328 per share was paid on December 6, 2022 in the aggregate amount of $180.3 million. A quarterly cash dividend of $0.358 per share was declared on February 2, 2023 and will be paid on March 7, 2023 to stockholders of record as of February 21, 2023. The Company expects the March 2023 payment of its quarterly cash dividend to be approximately $196.0 million.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations** 

**Note Regarding Forward-looking Statements**

This report, including "Part I – Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Part II - Item 1A. Risk Factors" contains certain forward-looking statements that involve risks and uncertainties, including statements regarding our strategy, financial performance and revenue sources. We use words such as "anticipate," "believe," "can," "continue," "could," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Our actual results could differ materially from the results anticipated in these forward-looking statements as a result of certain factors including those set forth under "Risk Factors," beginning at page [37](#i32521453983b4a318e7d58b6f396f928_235) and elsewhere in this Form 10-Q. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements. We disclaim any obligation to update information contained in any forward-looking statement. These forward-looking statements include, without limitation, statements regarding the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that certain supply chain constraints will continue through much of calendar 2023;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• That local governments could require us or our suppliers to reduce production, cease operations, or implement mandatory vaccine requirements, and we could experience constraints in fulfilling customer orders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that we will experience period-to-period fluctuations in operating results due to general industry or economic conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effects that uncertain global economic conditions and fluctuations in the global credit and equity markets may have on our financial condition and results of operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effects and amount of competitive pricing pressure on our product lines and modest pricing declines in certain of our more mature proprietary product lines;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to moderate future average selling price declines;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of product mix, capacity utilization, yields, fixed cost absorption, competition and economic conditions on gross margin;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The amount of, and changes in, demand for our products and those of our customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of national security protections, trade restrictions and changes in tariffs, including those impacting China;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that in the future we will acquire additional businesses that we believe will complement our existing businesses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that in the future we will enter into joint development agreements or other strategic relationships with other companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The level of orders that will be received and shipped within a quarter, including the impact of our product lead times;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our intent to vigorously defend our legal positions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our goal to continue to be more efficient with our selling, general and administrative expenses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that our days of inventory at March 31, 2023 will be 157 to 164 days;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our belief that customers recognize our products and brand name and use distributors as an effective supply channel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The accuracy of our estimates of the useful life and values of our property, assets and other liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to increase the proprietary portion of our analog product line and the effect of such an increase;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of any supply disruption we may experience;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to effectively utilize our facilities at appropriate capacity levels;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The likelihood of our stock price to fluctuate in the future;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to maintain manufacturing yields;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The maintenance of our competitive position based on our investments in new and enhanced products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The success of our licensing business depending on the continued market acceptance of our technologies and on our ability to further develop such technologies and to introduce new technologies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The potential of the Preferred Supply Program and the long-term supply agreements to satisfy commitments to our suppliers, enable us to forecast capital equipment requirements and employee needs, ramp up manufacturing and manufacture products more efficiently;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The cost effectiveness of using our own assembly and test operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The greater functionality in new product designs afforded by our proprietary design and manufacturing processes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our plans to continue to transition certain outsourced assembly and test capacity to our internal facilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation of continued investment in expanding our manufacturing capacity through calendar 2023 and during the next twelve months;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The continued development of the embedded control market based on our strong technical service presence;

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that foundry capacity will continue to be limited due to strong demand for wafers across the industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that we will continue to operate our manufacturing facilities at or above normal capacity if the current supply constraints relative to demand continue;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our anticipated level of capital expenditures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectations regarding cash inflows and outflows under our long-term supply arrangements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The continuation and amount of quarterly cash dividends;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The sufficiency of our existing sources of liquidity to finance anticipated capital expenditures and otherwise meet our anticipated cash requirements, and the effects that our contractual obligations are expected to have on them;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our belief that the capital expenditures to be incurred over the next twelve months will provide sufficient manufacturing capacity to support the growth of our production capabilities for our new products and technologies and to bring in-house more of the production requirements that are currently outsourced;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of seasonality on our business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our belief that our IT system compromise has not had a material adverse effect on our business or resulted in any material damage to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that we will continue to be the target of cyber-attacks, computer viruses, unauthorized access and other attempts to breach or otherwise compromise the security of our IT systems and data;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of the resolution of legal actions on our business, and the accuracy of our assessment of the probability of loss and range of potential loss;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our plans to pursue all available administrative and judicial remedies necessary to resolve the Statutory Notice of Deficiency we received;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation regarding the treatment of our unrecognized tax benefits in calendar year 2023;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our belief that the expiration of any tax holidays will not have a material impact on our effective tax rate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of the geographical dispersion of our earnings and losses on our effective tax rate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our belief that the estimates used in preparing our condensed consolidated financial statements are reasonable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our actions to vigorously and aggressively defend and protect our intellectual property on a worldwide basis;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to obtain patents and intellectual property licenses and minimize the effects of litigation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The level of risk we are exposed to for product liability claims or indemnification claims;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of fluctuations in market interest rates on our income and/or cash flows;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect of fluctuations in currency rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to increase our borrowings or seek additional equity or debt financing to maintain or expand our facilities, or to fund cash dividends, share repurchases, acquisitions or other corporate activities, and that the timing and amount of such financing requirements will depend on a number of factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectations regarding the amounts and timing of repurchases under our stock repurchase program;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our expectation that our reliance on third-party contractors may increase over time as our business grows;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to collect accounts receivable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact of the legislative and policy changes implemented or which may be implemented by the current administration, on our business and the trading price of our stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our plans to continue to undertake efforts to conform to current regulatory obligations and evolving best practices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our plans to continue to comply with applicable U.S. sanctions regarding Ukraine;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The costs we expect to incur associated with certain disclosure requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Estimates and plans regarding pension liability and payments expected to be made for benefits earned; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impact on our business stemming from Russia's invasion of Ukraine.

Our actual results could differ materially from the results anticipated in these forward-looking statements as a result of certain factors including those set forth in "Item 1A. Risk Factors," and elsewhere in this Form 10-Q. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements. We disclaim any obligation to update the information contained in any forward-looking statement.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Introduction**

The following discussion should be read in conjunction with the condensed consolidated financial statements and the related notes that appear elsewhere in this document.

We begin our Management's Discussion and Analysis of Financial Condition and Results of Operations with a summary of business and macroeconomic developments followed by a summary of our overall business strategy to give the reader an overview of the goals and overall direction of our business. This is followed by a discussion of the Critical Accounting Policies and Estimates that we believe are important to understanding the assumptions and judgments incorporated in our reported financial results. We then discuss our Results of Operations for the three and nine months ended December 31, 2022 compared to the three and nine months ended December 31, 2021, followed by an analysis of changes in our balance sheet and cash flows, and discuss our financial commitments in the section titled "Liquidity and Capital Resources."

**Business and Macroeconomic Environment**

In the first half of calendar 2020, the COVID-19 pandemic initially resulted in a global disruption in economic activity by adversely affecting production, creating supply chain and market disruption, and adversely impacting businesses and individuals. However, in the second half of fiscal 2021, business conditions were unexpectedly strong as businesses and individuals adapted to the effects of the pandemic. In response to global supply constraints, we worked to mitigate the impact of the pandemic on our business by qualifying alternative suppliers, increasing our inventory of raw materials, ramping our internal factories and adding assembly and test capacity to increase our manufacturing capability while securing additional capacity with our subcontractors wherever possible. Strong customer demand for our products continued to outpace capacity in the first half of fiscal 2023 and in fiscal 2022. While our business remained strong in the third quarter of fiscal 2023, our overall business in China, which is one of our key markets, was adversely impacted by the COVID-19 lock-downs and the subsequent rapid transmission of COVID-19 when lock-downs in China were lifted. In addition, rising interest rates and high inflation in the U.S. may result in a slowdown in the global economy and reduce customer demand in our industry. We are unable to predict the timing or impact of any such slowdown on our business. Despite supply gradually improving in recent quarters, and more improvement expected in the coming quarters, we expect that certain supply chain constraints will persist through much of calendar 2023; however, recent uncertainty in the U.S. and world economies may lessen the impact of such constraints on our business in future periods.

In order to provide prioritized capacity to our customers, we launched our Preferred Supply Program in February 2021, which provides our customers with prioritized capacity beginning six months after the customer places an order for 12 months of continuous, non-cancellable and non-reschedulable backlog. Since the first quarter of calendar 2022, we have been entering into certain long-term supply agreements with our customers for products that will be shipped in future periods. We also entered into certain long-term supply agreements with key suppliers.

In response to the pandemic, we have taken proactive preventative measures to enable a safe environment for our employees and operation of our manufacturing sites. While our global manufacturing sites have been fully operational in recent periods, we strategically implemented plans intended to provide more assurance of business continuity in the event severe outbreaks or government requirements were to impact our operations.

**Strategy**

We develop, manufacture and sell smart, connected and secure embedded control solutions used by our customers for a wide variety of applications. Our strategic focus includes general purpose and specialized 8-bit, 16-bit, and 32-bit microcontrollers, microprocessors, analog, FPGA, and memory products. With over 30 years of technology leadership, our broad product portfolio is a Total System Solution (TSS) for our customers that can provide a large portion of the silicon requirements in their applications. TSS is a combination of hardware, software and services which help our customers increase their revenue, reduce their costs and manage their risks compared to other solutions. Our synergistic product portfolio empowers disruptive growth trends, including 5G, data centers, sustainability, Internet of Things (IoT) and edge computing, advanced driver assist systems (ADAS) and autonomous driving, and electric vehicles, in key end markets such as automotive, aerospace and defense, communications, consumer appliances, data centers and computing, and industrial.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

Our manufacturing operations include wafer fabrication, wafer probe, assembly and test. The ownership of a substantial portion of our manufacturing resources is an important component of our business strategy, enabling us to maintain a high level of manufacturing control, resulting in us being one of the lowest cost producers in the embedded control industry. By owning wafer fabrication facilities and our assembly and test operations, and by employing statistical techniques (statistical process control, designed experiments and wafer level monitoring), we have been able to achieve and maintain high production yields. Direct control over manufacturing resources allows us to shorten our design and production cycles. This control also allows us to capture a portion of the wafer manufacturing and assembly and testing profit margin. We outsource a significant portion of our manufacturing requirements to third parties and the amount of our outsourced manufacturing has increased in recent years due to our acquisitions of Microsemi and other companies that outsourced all or substantial portions of their manufacturing. Although we recently considered building a 300 mm U.S. based wafer fabrication facility for specialized, trailing edge process technologies, we have concluded that our business objectives could likely be better achieved through relationships with our foundry suppliers.

We employ proprietary design and manufacturing processes in developing our embedded control products. We believe our processes afford us both cost-effective designs in existing and derivative products and greater functionality in new product designs. While many of our competitors develop and optimize separate processes for their logic and memory product lines, we use a common process technology for both microcontroller and non-volatile memory products. This allows us to more fully leverage our process research and development costs and to deliver new products to market more rapidly. Our engineers utilize advanced computer-aided design tools and software to perform circuit design, simulation and layout, and our in-house photomask and wafer fabrication facilities enable us to rapidly verify design techniques by processing test wafers quickly and efficiently.

We are committed to continuing our investment in new and enhanced products, including development systems, and in our design and manufacturing process technologies. We believe these investments are significant factors in maintaining our competitive position. Our current research and development activities focus on the design of new microcontrollers, digital signal controllers, memory, analog and mixed-signal products, FPGAs, timing systems, Flash-IP, development systems, software and application-specific software libraries. We are also developing new design and process technologies to achieve further cost reductions and performance improvements in our products.

We market and sell our products worldwide primarily through a network of direct sales personnel and distributors. Our direct sales force focuses on a wide variety of strategic accounts in three geographical markets: the Americas, Europe and Asia. We currently maintain sales and technical support centers in major metropolitan areas in all three geographic markets. We believe that a strong technical service presence is essential to the continued development of the embedded control market. Many of our CEMs, ESEs, and sales managers have technical degrees or backgrounds and have been previously employed in high technology environments. We believe that the technical and business knowledge of our sales force is a key competitive advantage in the sale of our products. The primary mission of our ESE team is to provide technical assistance to customers and to conduct periodic training sessions for the balance of our sales team. ESEs also frequently conduct technical seminars and workshops in major cities around the world or through online webcasts. Our licensing division has dedicated sales, technology, design, product, test and reliability personnel that support the requirements of our licensees.

See the risk factor captioned "*Our operating results are impacted by seasonality and wide fluctuations of supply and demand in the industry*" on page [43](#i78b37e7b96dd48848e77145604712819_105194) for discussion of the impact of seasonality on our business.

**Critical Accounting Policies and Estimates**

Except for the changes discussed in "Recently Adopted Accounting Pronouncements" in Note 2 to our condensed consolidated financial statements in this Form 10-Q, there were no changes to our critical accounting policies and estimates during the first nine months of the fiscal year ending March 31, 2023 compared to our "Critical Accounting Policies and Estimates" as previously described in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended March 31, 2022.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Results of Operations**

The following table sets forth certain operational data as a percentage of net sales for the periods covered by this report:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | 2022 | 2021 |
| Net sales | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of sales | 32.2 | 34.4 | 32.7 | 35.1 |
| Gross profit | 67.8 | 65.6 | 67.3 | 64.9 |
| Research and development | 13.0 | 14.0 | 13.2 | 14.7 |
| Selling, general and administrative | 9.4 | 10.1 | 9.6 | 10.7 |
| Amortization of acquired intangible assets | 7.7 | 12.2 | 8.1 | 13.0 |
| Special charges (income) and other, net | 0.3 |  | (0.1) | 0.4 |
| Operating income | 37.4% | 29.3% | 36.5% | 26.1% |

---

*Net Sales*

We operate in two industry segments and engage primarily in the design, development, manufacture and sale of semiconductor products as well as the licensing of our SuperFlash and other technologies. We sell our products to distributors and OEMs in a broad range of markets, perform ongoing credit evaluations of our customers and generally require no collateral. In certain circumstances, a customer's financial condition may require collateral, and, in such cases, the collateral would be typically provided in the form of letters of credit.

The following table summarizes our net sales for the periods covered by this report (dollars in millions):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | 2021 | Change | 2022 | 2021 | Change |
| Net sales | $2169.2 | $1757.5 | 23.4% | $6206.0 | $4976.7 | 24.7% |

---

The increases in net sales in the three and nine months ended December 31, 2022 compared to the three and nine months ended December 31, 2021 were primarily due to strong business conditions that began in the second half of fiscal 2021 as businesses and individuals adapted to the effects of the COVID-19 pandemic. Business conditions continued to be strong in the three and nine months ended December 31, 2022 although there is increased uncertainty as to the future direction of the global economy due to rising interest rates and high inflation. Additionally, semiconductor industry conditions have resulted in increased costs throughout our supply chain, which we have been passing on to our customers in the form of price increases. Our price increases were implemented at various times and in various amounts throughout fiscal 2022 with respect to our very broad range of customers and products. These price increases also contributed to the increase in net sales during the three and nine months ended December 31, 2022 compared to the three and nine months ended December 31, 2021. Due to the complexity of the implementation of the price increases and the changes in product, geographic and customer mix, we are not able to quantify the impact of the price increases on our net sales. Additionally, the increase in net sales was positively impacted by strength in all of our product lines. See our "Business and Macroeconomic Environment" discussion above for further information on our business outlook.

Other factors that we believe contributed to changes in our reported net sales for the three and nine months ended December 31, 2022 compared to the three and nine months ended December 31, 2021 and which are drivers of long-term trends in our net sales but which factors we are not able to quantify include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• semiconductor industry conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our various new product offerings that have increased our served available market;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• customers' increasing needs for the flexibility offered by our programmable solutions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increasing semiconductor content in our customers' products through our Total Systems Solutions.

We sell a large number of products to a large and diverse customer base and there was not any single product or customer that accounted for a material portion of the change in our net sales in the three and nine months ended December 31, 2022 or the three and nine months ended December 31, 2021.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

Net sales by product line for the periods covered by this report were as follows (dollars in millions):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | % | 2021 | % | 2022 | % | 2021 | % |
| Microcontrollers | $1221.3 | 56.3 | $972.2 | 55.3 | $3463.8 | 55.9 | $2768.7 | 55.6 |
| Analog | 606.5 | 28.0 | 500.5 | 28.5 | 1759.0 | 28.3 | 1423.5 | 28.6 |
| Other | 341.4 | 15.7 | 284.8 | 16.2 | 983.2 | 15.8 | 784.5 | 15.8 |
| Total net sales | $2169.2 | 100.0 | $1757.5 | 100.0 | $6206.0 | 100.0 | $4976.7 | 100.0 |

---

<u>Microcontrollers</u>

Our microcontroller product line represents the largest component of our total net sales. Microcontrollers and associated application development systems accounted for approximately 56.3% and 55.9% of our net sales for the three and nine months ended December 31, 2022, respectively, compared to approximately 55.3% and 55.6% of our net sales for the three and nine months ended December 31, 2021, respectively.

Net sales of our microcontroller products increased 25.6% and 25.1% in the three and nine months ended December 31, 2022, respectively, compared to the three and nine months ended December 31, 2021. These sales increases were due primarily to strength in demand for our microcontroller products in end markets that we serve and our price increases.

Historically, average selling prices in the semiconductor industry decrease over the life of any particular product. However, the overall average selling prices of our microcontroller products have increased in recent periods and have remained relatively stable over time due to the proprietary nature of these products. We have in the past been able to, and expect in the future to be able to, moderate average selling price declines in our microcontroller product lines by introducing new products with more features and higher prices.

<u>Analog</u>

Our analog product line includes analog, interface, mixed signal and timing products. Our analog product line accounted for approximately 28.0% and 28.3% of our net sales for the three and nine months ended December 31, 2022, respectively, compared to approximately 28.5% and 28.6% of our net sales for the three and nine months ended December 31, 2021, respectively.

Net sales from our analog product line increased 21.2% and 23.6% in the three and nine months ended December 31, 2022, respectively, compared to the three and nine months ended December 31, 2021, primarily due to strength in demand for our analog products in end markets that we serve and our price increases.

We consider a majority of the products in our analog product line to be proprietary in nature, where prices are relatively stable, similar to the pricing stability experienced in our microcontroller products. The non-proprietary portion of our analog product line will experience price fluctuations, driven primarily by the current supply and demand for those products.

<u>Other</u>

Our other product line includes FPGA products, royalties associated with licenses for the use of our SuperFlash and other technologies, sales of our intellectual property, fees for engineering services, memory products, timing systems, manufacturing services (wafer foundry and assembly and test subcontracting), legacy application specific integrated circuits, and certain products for aerospace applications. Revenue from these services and products accounted for approximately 15.7% and 15.8% of our net sales for the three and nine months ended December 31, 2022, respectively, compared to approximately 16.2% and 15.8% of our net sales for the three and nine months ended December 31, 2021, respectively.

Net sales related to these services and products increased 19.9% and 25.3% in the three and nine months ended December 31, 2022, respectively, compared to the three and nine months ended December 31, 2021. The increases in net sales were primarily due to strength in demand for our products in end markets that we serve and our price increases. Net sales of our other product line can fluctuate over time based on general economic and semiconductor industry conditions as well as changes in demand for our FPGA products, licenses, engineering services, memory products, timing systems, and manufacturing services (wafer foundry and assembly and test subcontracting).

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

<u>Distribution</u>

Distributors accounted for approximately 48% and 47% of our net sales in the three and nine months ended December 31, 2022, respectively, and approximately 45% and 48% of our net sales in the three and nine months ended December 31, 2021, respectively. The lower distribution percentages in the second half fiscal 2022 and the first half of fiscal 2023 were due to lower Preferred Supply Program participation among our distributors. With the exception of Arrow Electronics, our largest distributor, which made up 10% of our net sales, no other distributor or end customer accounted for more than 10% of our net sales in the nine months ended December 31, 2022. In the nine months ended December 31, 2021, no distributor or end customer accounted for more than 10% of our net sales. Our distributors focus primarily on servicing the product requirements of a broad base of diverse customers. We believe that distributors provide an effective means of reaching this broad and diverse customer base. We believe that customers recognize Microchip for its products and brand name and use distributors as an effective supply channel.

Generally, we do not have long-term agreements with our distributors and we, or our distributors, may terminate our relationships with each other with little or no advance notice, with the exception of orders placed under our Preferred Supply Program or otherwise designated as non-cancellable. The loss of, or the disruption in the operations of, one or more of our distributors could reduce our future net sales in a given quarter and could result in an increase in inventory returns.

At December 31, 2022, our distributors maintained 22 days of inventory of our products compared to 17 days at March 31, 2022. Over the past ten fiscal years, the days of inventory maintained by our distributors have fluctuated between approximately 17 days and 40 days. Inventory holding patterns at our distributors may have a material impact on our net sales.

<u>Sales by Geography</u>

Sales by geography for the periods covered by this report were as follows (dollars in millions):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended December 31, | Three Months Ended December 31, | Three Months Ended December 31, | Three Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, | Nine Months Ended December 31, |
| | 2022 | % | 2021 | % | 2022 | % | 2021 | % |
| Americas | $567.4 | 26.2 | $439.3 | 25.0 | $1588.7 | 25.6 | $1232.2 | 24.8 |
| Europe | 428.6 | 19.8 | 360.4 | 20.5 | 1242.0 | 20.0 | 994.7 | 20.0 |
| Asia | 1173.2 | 54.0 | 957.8 | 54.5 | 3375.3 | 54.4 | 2749.8 | 55.2 |
| Total net sales | $2169.2 | 100.0 | $1757.5 | 100.0 | $6206.0 | 100.0 | $4976.7 | 100.0 |

---

Americas sales include sales to customers in the U.S., Canada, Central America and South America. Sales to foreign customers accounted for approximately 77% of our total net sales in each of the three and nine months ended December 31, 2022 compared to approximately 78% of our total net sales in each of the three and nine months ended December 31, 2021. Substantially all of our foreign sales are U.S. dollar denominated. Our sales force in the Americas and Europe supports a significant portion of the design activity for products which are ultimately shipped to Asia.

*Gross Profit*

Our gross profit in the three months ended December 31, 2022 was $1.47 billion, or 67.8% of net sales, compared to $1.15 billion, or 65.6% of net sales, in the three months ended December 31, 2021. Our gross profit in the nine months ended December 31, 2022 was $4.18 billion, or 67.3% of net sales, compared to $3.23 billion, or 64.9% of net sales, in the nine months ended December 31, 2021. Gross margin increased in the three and nine months ended December 31, 2022 compared to the three and nine months ended December 31, 2021 primarily as a result of higher utilization of our factories due to increased customer demand.

Our overall inventory levels were $1.17 billion at December 31, 2022, compared to $854.4 million at March 31, 2022. We maintained 152 days of inventory on our balance sheet at December 31, 2022 compared to 125 days of inventory at March 31, 2022. Inventory increased primarily as a result of our efforts to balance manufacturing production, demand and inventory levels. Our inventory levels are impacted by the timing of receipt of raw materials, foundry wafers, and strategic last time buy materials and completion of finished goods. We expect our days of inventory levels at March 31, 2023 to be 157 to 164 days.

We operate assembly and test facilities in Thailand, the Philippines, and other locations throughout the world. Approximately 59% of our assembly requirements were performed in our internal assembly facilities during each of the three and nine months ended December 31, 2022 and December 31, 2021. Approximately 68% and 67% of our test requirements

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

were performed in our internal test facilities during the three and nine months ended December 31, 2022, respectively, compared to approximately 63% and 64% during the three and nine months ended December 31, 2021, respectively. The percentage of our assembly and test operations that are performed internally fluctuates over time based on supply and demand conditions in the semiconductor industry, our internal capacity capabilities and our acquisition activities. We believe that the assembly and test operations performed at our internal facilities provide us with significant cost savings compared to third party contractor assembly and test costs, as well as increased control over these portions of the manufacturing process. We plan to continue to invest in assembly and test equipment to increase our internal capacity capabilities and transition certain outsourced assembly and test capacity to our internal facilities.

We rely on outside wafer foundries for a significant portion of our wafer fabrication requirements. Approximately 63% of our net sales came from products that were produced at outside wafer foundries during each of the three and nine months ended December 31, 2022, compared to approximately 61% and 60% during the three and nine months ended December 31, 2021, respectively.

*Research and Development*

R&D expenses for the three months ended December 31, 2022 were $282.4 million, or 13.0% of net sales, compared to $245.4 million, or 14.0% of net sales, for the three months ended December 31, 2021. R&D expenses for the nine months ended December 31, 2022 were $820.0 million, or 13.2% of net sales, compared to $730.0 million, or 14.7% of net sales, for the nine months ended December 31, 2021. We are committed to investing in new and enhanced products, including development systems software, and in our design and manufacturing process technologies. We believe these investments are significant factors in maintaining our competitive position. R&D costs are expensed as incurred. Assets purchased to support our ongoing research and development activities are capitalized when related to products which have achieved technological feasibility or that have alternative future uses and are amortized over their expected useful lives. R&D expenses include labor, depreciation, masks, prototype wafers, and expenses for the development of process technologies, new packages, and software to support new products and design environments.

R&D expenses increased $37.0 million, or 15.1%, for the three months ended December 31, 2022 over the same period last year. R&D expenses increased $90.0 million, or 12.3%, for the nine months ended December 31, 2022 over the same period last year. The primary reasons for the increases in R&D costs were increases in headcount and employee compensation as well as higher product development costs.

R&D expenses fluctuate over time, primarily due to revenue and operating expense investment levels.

*Selling, General and Administrative*

Selling, general and administrative expenses for the three months ended December 31, 2022 were $202.9 million, or 9.4% of net sales, compared to $177.5 million, or 10.1% of net sales, for the three months ended December 31, 2021. Selling, general and administrative expenses for the nine months ended December 31, 2022 were $594.2 million, or 9.6% of net sales, compared to $531.7 million, or 10.7% of net sales, for the nine months ended December 31, 2021. Our goal is to continue to be more efficient with our selling, general and administrative expenses. Selling, general and administrative expenses include salary expenses related to field sales, marketing and administrative personnel, advertising and promotional expenditures and legal expenses as well as costs related to our direct sales force, CEMs and ESEs who work remotely from sales offices worldwide to stimulate demand by assisting customers in the selection and use of our products.

Selling, general and administrative expenses increased $25.4 million, or 14.3%, for the three months ended December 31, 2022 over the same period last year. Selling, general and administrative expenses increased $62.5 million, or 11.8%, for the nine months ended December 31, 2022 over the same period last year. The primary reasons for the increases in selling, general and administrative expenses were increases in headcount and employee compensation.

Selling, general and administrative expenses fluctuate over time, primarily due to revenue and operating expense investment levels.

*Amortization of Acquired Intangible Assets*

Amortization of acquired intangible assets for the three and nine months ended December 31, 2022 was $167.4 million and $502.5 million, respectively, compared to $215.7 million and $647.0 million for the three and nine months ended

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

December 31, 2021, respectively. The primary reason for the decreases in acquired intangible asset amortization was due to the use of accelerated amortization methods for assets placed in service in previous fiscal years.

*Special Charges (Income) and Other, Net* 

During the three and nine months ended December 31, 2022, we incurred special charges and other, net of $6.5 million and earned special income and other, net of $6.1 million, respectively. The special charges and other, net incurred during the three months ended December 31, 2022, primarily related to restructuring of acquired and existing wafer fabrication operations to increase operational efficiency. The special income and other, net earned during the nine months ended December 31, 2022, primarily related to a favorable resolution of a previously accrued legal matter partially offset by restructuring costs of acquired and existing wafer fabrication operations to increase operational efficiency. During the three and nine months ended December 31, 2021, we earned special income and other, net of $0.3 million and incurred special charges and other, net of $20.4 million, respectively. The special income and other, net earned during the three months ended December 31, 2021, and the special charges and other, net incurred during the nine months ended December 31, 2021, primarily related to restructuring of acquired and existing wafer fabrication operations to increase operational efficiency, legal contingencies and exiting non-manufacturing facilities including contract termination costs, employee severance, and the disposal of assets.

*Other Income (Expense)*

Interest income in the three and nine months ended December 31, 2022 was $0.8 million and $1.1 million, respectively, compared to $0.1 million and $0.5 million, respectively, for the three and nine months ended December 31, 2021.

Interest expense in the three and nine months ended December 31, 2022 was $52.8 million and $156.4 million, respectively, compared to $62.1 million and $199.2 million, respectively, for the three and nine months ended December 31, 2021. The primary reasons for the decreases in interest expense relates to the adoption of ASU 2020-06 on April 1, 2022, which eliminated the amortization of debt discount on our Convertible Debt, and the cumulative pay down of our debt offset by higher interest rates on our outstanding variable rate debt.

During the nine months ended December 31, 2022, we recognized losses of $8.3 million related to the settlement of a portion of our outstanding 2015 Senior Convertible Debt, our 2017 Senior Convertible Debt, and our 2017 Junior Convertible Debt. During the three and nine months ended December 31, 2021, we recognized losses of $16.1 million and $101.6 million, respectively, related to the settlement of a portion of our outstanding 2015 Senior Convertible Debt, our 2017 Senior Convertible Debt, and our 2017 Junior Convertible Debt as well as the amendment and restatement of our Credit Agreement and the repayment of $1.00 billion aggregate principal amount outstanding of our 3.922% 2021 Notes.

Other income, net was $2.6 million and $3.5 million for the three and nine months ended December 31, 2022, respectively, compared to $4.6 million and $3.5 million for the three and nine months ended December 31, 2021, respectively.

*Provision for Income Taxes*

Our provision for income taxes is attributable to U.S. federal, state, and foreign income taxes. Our effective tax rate for the nine months ended December 31, 2022, increased significantly over the same period last year primarily due to a provision in the TCJA. Research and development expenditures incurred after March 31, 2022, must be capitalized and amortized ratably over five or fifteen years for tax purposes, depending on the location in which the research activities are conducted. The resulting capitalization of research and development expenditures impacts the calculation of our GILTI, which is treated as a period cost, beginning in the first quarter of fiscal 2023.

We are subject to taxation in many jurisdictions in which we have operations. The effective tax rates that we pay in these jurisdictions vary widely, but they are generally lower than our combined U.S. federal and state effective tax rate. Our domestic blended statutory tax rate in each of the nine months ended December 31, 2022 and December 31, 2021 was approximately 22%. Our non-U.S. blended statutory tax rates in the nine months ended December 31, 2022 and December 31, 2021 were lower than this amount. The difference in rates applicable in foreign jurisdictions results from a number of factors, including lower statutory rates, tax holidays, financing arrangements and other factors. Our effective tax rate has been and will continue to be impacted by the geographical dispersion of our earnings and losses.

Our foreign tax rate differential benefit primarily relates to our operations and assets in Thailand, Malta, and Ireland. Our Thailand manufacturing operations are currently subject to numerous tax holidays granted to us based on our investment in

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

property, plant, and equipment in Thailand. Our tax holiday periods in Thailand expire at various times in the future; however, we actively seek to obtain new tax holidays, otherwise we will be subject to tax at the statutory tax rate of 20%. We do not expect the future expiration of any of our tax holiday periods in Thailand to have a material impact on our effective tax rate. The remaining material components of foreign income taxed at a rate lower than the U.S. are earnings accrued in Ireland at a 12.5% statutory tax rate and earnings accrued in Malta at a 5.0% statutory tax rate.

In September 2021, we received a Statutory Notice of Deficiency (Notice) from the Internal Revenue Service (IRS) for fiscal 2007 through fiscal 2012. The disputed amounts largely relate to transfer pricing matters. We firmly believe that the assessments are without merit and plan to pursue all available administrative and judicial remedies necessary to resolve this matter. In December 2021, we filed a petition in the United States Tax Court challenging the Notice. We intend to vigorously defend our position and we are confident in our ability to prevail on the merits. We regularly assess the likelihood of adverse outcomes resulting from examinations such as this to determine the adequacy of our tax reserves. We believe that the final adjudication of this matter will not have a material impact on our consolidated financial position, results of operations or cash flows and that we have adequate tax reserves for all tax matters. However, the ultimate outcome of disputes of this nature is uncertain, and if the IRS were to prevail on all of its assertions, the assessed tax, penalties, and deficiency interest could have a material adverse impact on our financial position, results of operations or cash flows.

Various taxing authorities in the U.S. and other countries in which we do business are increasing their scrutiny of the tax structures employed by businesses. Companies of our size and complexity are regularly audited by the taxing authorities in the jurisdictions in which they conduct significant operations. For U.S. federal, and in general for U.S. state tax returns, our fiscal 2007 and later tax returns remain effectively open for examination by the taxing authorities. We are currently being audited by the tax authorities in the U.S. and in various foreign jurisdictions. At this time, we do not know what the outcome of these audits will be. We record benefits for uncertain tax positions based on an assessment of whether it is more likely than not that the tax positions will be sustained based on their technical merits under currently enacted law. If this threshold is not met, no tax benefit of the uncertain tax position is recognized. If the threshold is met, we recognize the largest amount of the tax benefit that is more than 50% likely to be realized upon ultimate settlement.

In August 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (Inflation Reduction Act) into law. The Inflation Reduction Act includes a new corporate alternative minimum tax (Corporate AMT) of 15% on the adjusted financial statement income (AFSI) of corporations with average AFSI exceeding $1.00 billion over a three-year period. The Corporate AMT is effective for us beginning in fiscal 2024. We are evaluating the Corporate AMT and its potential impact on our future U.S. tax expense, cash taxes, and effective tax rate.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Liquidity and Capital Resources** 

We had $288.9 million in cash and cash equivalents at December 31, 2022, a decrease of $30.5 million from the March 31, 2022 balance.

*Operating Activities*

Net cash provided by operating activities was $2.91 billion in the nine months ended December 31, 2022, primarily due to higher net income of $1.63 billion, adjusted for non-cash and non-operating charges of $1.09 billion and net cash inflows of $190.3 million from changes in our operating assets and liabilities. The primary drivers of the changes in operating assets and liabilities in the nine months ended December 31, 2022 include an increase in trade accounts receivable driven primarily by higher net sales and an increase in inventories related to increased raw materials, foundry wafers, finished goods, and receipt of strategic last time buy materials, offset by increases in accrued and other liabilities driven by higher sales related reserves, including cash collected from customers under our long-term supply agreements. The cash collected from these long-term supply agreements is refundable when customers fulfill their purchase commitments. In future periods, we expect cash inflows under these arrangements to decrease, and cash outflows to increase as amounts are refunded to customers (see "Note 4. Net Sales" to our condensed consolidated financial statements). Net cash provided by operating activities was $2.10 billion in the nine months ended December 31, 2021, primarily due to net income of $847.6 million, adjusted for non-cash and non-operating charges of $1.16 billion and net cash inflows of $91.6 million from changes in our operating assets and liabilities.

*Investing Activities*

Net cash used in investing activities was $448.7 million in the nine months ended December 31, 2022 compared to $335.0 million in the nine months ended December 31, 2021. During the nine months ended December 31, 2022 and December 31, 2021, net investing activities primarily related to capital purchases and investments in other assets.

Our level of capital expenditures varies from time to time as a result of actual and anticipated business conditions. Capital expenditures in the nine months ended December 31, 2022 were $373.5 million compared to $255.5 million in the nine months ended December 31, 2021. Capital expenditures were primarily for the expansion of production capacity and the addition of research and development equipment. We currently expect to invest between $400 million and $500 million in equipment and facilities during the next twelve months. We believe that the capital expenditures anticipated to be incurred over the next twelve months will provide sufficient manufacturing capacity to support the growth of our production capabilities for our new products and technologies and to bring in-house more of our production requirements that are currently outsourced. We expect to finance our capital expenditures through our existing cash balances and cash flows from operations. In August 2022, the U.S. government enacted the CHIPS Act which is to provide billions of dollars of cash incentives and a new investment tax credit to increase domestic manufacturing capacity in our industry. Such incentives may potentially be available to us, our competitors and foundries; however, there can be no assurance that we will receive any such incentives, what the amount and timing of any incentive we receive will be, as to which other companies will receive incentives and whether the legislation will have a positive or negative impact on our competitive position.

*Financing Activities*

Net cash used in financing activities was $2.49 billion in the nine months ended December 31, 2022 compared to $1.73 billion in the nine months ended December 31, 2021. Significant transactions affecting our net financing cash flows included:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• in the first nine months of fiscal 2023, $1.32 billion of cash used to pay down certain principal of our debt, including our 2015 Senior Convertible Debt, our 2017 Senior Convertible Debt, our 2017 Junior Convertible Debt, and our Revolving Credit Facility, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• in the first nine months of fiscal 2022, $1.17 billion of cash used to pay down certain principal of our debt, including the cash portion of the settlement of our 2015 Senior Convertible Debt, our 2017 Senior Convertible Debt and our 2017 Junior Convertible Debt, our Revolving Credit Facility and our 3.922% 2021 Notes, partially funded by the issuance of our senior notes, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• in the first nine months of fiscal 2023 and fiscal 2022, we paid cash dividends to our stockholders of $499.4 million and $363.0 million, respectively, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• in the first nine months of fiscal 2023 and fiscal 2022, we repurchased shares of our common stock for $671.9 million and $166.0 million, respectively.

In December 2021, we amended and restated our Credit Agreement in its entirety. The amended and restated Credit Agreement provides for an unsecured revolving loan facility up to $2.75 billion that terminates on December 16, 2026. The

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

Credit Agreement also permits us, subject to certain conditions, to add one or more incremental term loan facilities or increase the revolving loan commitments up to $750.0 million. As of December 31, 2022, the principal amount of our outstanding indebtedness was $6.62 billion. At December 31, 2022, we had $253.0 million of outstanding borrowings under the Revolving Credit Facility compared to $1.40 billion at March 31, 2022.

*Capital Returns*

In November 2021, our Board of Directors authorized the repurchase of up to $4.00 billion of our common stock in the open market or in privately negotiated transactions. In the first nine months of fiscal 2023, we repurchased approximately 9.6 million shares of our common stock for $671.9 million under this authorization. In the first nine months of fiscal 2022, we repurchased approximately 2.0 million shares of our common stock for $166.0 million under this authorization. As of December 31, 2022, approximately $2.90 billion remained available for repurchases under the program. As of December 31, 2022, we held approximately 30.0 million shares as treasury shares. Our current intent is to regularly repurchase shares of our common stock over time based on our cash generation, leverage metrics, and market conditions.

In October 2002, we announced that our Board of Directors had approved and instituted a quarterly cash dividend on our common stock. To date, our cumulative dividend payments have totaled approximately $5.55 billion. A quarterly cash dividend of $0.328 per share was paid on December 6, 2022 in the aggregate amount of $180.3 million. A quarterly dividend of $0.358 per share was declared on February 2, 2023 and will be paid on March 7, 2023 to stockholders of record as of February 21, 2023. We expect the aggregate cash dividend for the March 2023 quarter to be approximately $196.0 million. Our Board is free to change our dividend practices at any time and to increase or decrease the dividend paid, or not to pay a dividend on our common stock on the basis of our results of operations, financial condition, cash requirements and future prospects, and other factors deemed relevant by our Board. Our current intent is to increase our quarterly cash dividends depending upon market conditions, our results of operations, and potential changes in tax laws.

We believe that our existing sources of liquidity combined with cash generated from operations and borrowings under our Revolving Credit Facility will be sufficient to meet our currently anticipated cash requirements for at least the next 12 months. Our long-term liquidity requirements primarily arise from working capital requirements, interest and principal repayments related to our outstanding indebtedness, capital expenditures, cash dividends, share repurchases, and income tax payments. For additional information regarding our cash requirements see "Note 11. Commitments and Contingencies", "Note 7. Debt" and "Note 12. Income Taxes" to our condensed consolidated financial statements. The semiconductor industry is capital intensive and in order to remain competitive, we must constantly evaluate the need to make significant investments in capital equipment for both production and research and development and to expand our existing facilities or potentially construct new facilities. We may increase our borrowings under our Revolving Credit Facility or seek additional equity or debt financing from time to time to maintain or expand our wafer fabrication and product assembly and test facilities, for cash dividends, for share repurchases or for acquisitions or other purposes. The timing and amount of any such financing requirements will depend on a number of factors, including our level of dividend payments, changes in tax laws and regulations regarding the repatriation of offshore cash, demand for our products, changes in industry conditions, product mix, competitive factors and our ability to identify suitable acquisition candidates. We may from time to time seek to refinance certain of our outstanding notes or Convertible Debt through issuances of new notes or convertible debt, tender offers, exchange transactions or open market repurchases. Such issuances, tender offers or exchanges or purchases, if any, will depend on prevailing market conditions, our ability to negotiate acceptable terms, our liquidity position and other factors. There can be no assurance that any financing will be available on acceptable terms due to uncertainties resulting from rising interest rates, higher inflation, economic uncertainty, the COVID-19 pandemic, or other factors, and any additional equity financing would result in incremental ownership dilution to our existing stockholders. We also plan to pursue incentives under the CHIPS Act to increase our domestic manufacturing capacity; however, there can be no assurance that we will receive any such incentives or what the amount and timing of any incentive we receive will be.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

As of December 31, 2022, our long-term debt totaled $6.62 billion. We have no interest rate exposure to rate changes on our fixed rate debt, which totaled $6.37 billion as of December 31, 2022. We have interest rate exposure with respect to the $253.0 million of our variable interest rate debt outstanding under our Revolving Credit Facility as of December 31, 2022. A 50-basis point increase in interest rates would impact our expected annual interest expense for the next 12 months by approximately $1.3 million.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

As of the end of the period covered by this Quarterly Report on Form 10-Q, as required by paragraph (b) of Rule 13a-15 or Rule 15d-15 under the Exchange Act, we evaluated under the supervision of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Exchange Act). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls and procedures are designed to provide reasonable assurance that such information is accumulated and communicated to our management. Our disclosure controls and procedures include components of our internal control over financial reporting. Management's assessment of the effectiveness of our internal control over financial reporting is expressed at the level of reasonable assurance because a control system, no matter how well designed and operated, can provide only reasonable, but not absolute, assurance that the control system's objectives will be met.

**Changes in Internal Control over Financial Reporting**

During the three months ended December 31, 2022, there was no change in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings**

Refer to "Note 11. Commitments and Contingencies" to our condensed consolidated financial statements for information regarding legal proceedings.

**Item 1A. Risk Factors**

When evaluating Microchip and its business, you should give careful consideration to the factors below, as well as the information provided elsewhere in this Form 10-Q and in other filings we make with the SEC.

**Risk Factor Summary**

**Risks Related to Our Business, Operations, and Industry**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of global economic conditions on our operating results, net sales and profitability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of economic conditions on the financial viability of our licensees, customers, distributors, or suppliers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of the COVID-19 pandemic, increased tariffs or other factors affecting our suppliers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• dependency on wafer foundries and other contractors by our licensees and ourselves;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• dependence on foreign sales, suppliers, and operations, which exposes us to foreign political and economic risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limited visibility to product shipments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• intense competition in the markets we serve, leading to pricing pressures, reduced sales or market share;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ineffective utilization of our manufacturing capacity or failure to maintain manufacturing yields;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of seasonality and wide fluctuations of supply and demand in the industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• dependency on distributors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ability to introduce new products on a timely basis;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• business interruptions, including natural disasters, affecting our operations or that of key vendors, licensees or customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• technology licensing business exposes us to various risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• reliance on sales into governmental projects, and compliance with associated regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to grants from governments, agencies and research organizations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• future acquisitions or divestitures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• future impairments to goodwill or intangible assets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our failure to maintain proper and effective internal control and remediate future control deficiencies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• customer demands to implement business practices that are more stringent than legal requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ability to attract and retain qualified personnel; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the occurrence of events for which we are self-insured, or which exceed our insurance limits.

**Risks Related to Cybersecurity, Privacy, Intellectual Property, and Litigation**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• attacks on our IT systems, interruptions in our IT systems, or improper handling of data;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to compliance with privacy and data protection laws and regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to legal proceedings, investigations or claims;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to contractual relationships with our customers; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• protecting and enforcing our intellectual property rights.

**Risks Related to Taxation, Laws and Regulations**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of new accounting pronouncements or changes in existing accounting standards and practices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fines, restrictions or delay in our ability to export or import products, or increase costs associated with the manufacture or transfer of products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• outcome of future examinations of our income tax returns;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• exposure to greater than anticipated income tax liabilities, changes in or the interpretation of tax rules and regulations including the TCJA, the American Rescue Plan Act of 2021 (ARPA), or unfavorable assessments from tax audits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of the legislative and policy changes implemented globally by the current or future administrations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of stringent environmental, climate change, conflict-free minerals and other regulations or customer demands; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• requirement to fund our foreign pension plans.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Risks Related to Capitalization and Financial Markets**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of various factors on our future trading price of our common stock;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fluctuations in the amount and timing of our common stock repurchases;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to effectively manage current or future debt;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to generate sufficient cash flows or obtain access to external financing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• impact of conversion of our convertible debt on the ownership interest of our existing stockholders; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fluctuations in foreign currency exchange rates.

**Risks Related to Our Business, Operations, and Industry**

***Our operating results are impacted by global economic conditions and may fluctuate in the future due to a number of factors that could reduce our net sales and profitability.***

Our operating results are affected by a wide variety of factors that could reduce our net sales and profitability, many of which are beyond our control. Some of the factors that may affect our operating results include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• general economic, industry, public health or political conditions in the U.S. or internationally, including uncertain economic conditions in U.S., China and Europe, increases in interest rates, high inflation or further uncertainty surrounding the COVID-19 pandemic and its implications;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disruptions in our business, our supply chain or our customers' businesses due to public health concerns (including viral outbreaks such as COVID-19), cybersecurity incidents, terrorist activity, armed conflict, war (including Russia's invasion of Ukraine), worldwide oil prices and supply, fires, natural disasters or disruptions in the transportation system;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• availability of raw materials including rare earth minerals, supplies and equipment due to supply chain constraints or other factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• constrained availability from other electronic suppliers impacting our customers' ability to ship their products, which in turn may adversely impact our sales to those customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to continue to increase our factory capacity to respond to changes in customer demand;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to secure sufficient wafer foundry, assembly and testing capacity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increased costs and availability of raw materials, supplies, equipment, utilities, labor, and/or subcontracted services for wafers, assembly and test;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in demand or market acceptance of our products and products of our customers, and market fluctuations in the industries into which such products are sold;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the level of order cancellations or push-outs due to the impact of the COVID-19 pandemic or other factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• trade restrictions and increase in tariffs, including those on business in China, or focused on specific companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the mix of inventory we hold and our ability to satisfy orders from our inventory;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in utilization of our manufacturing capacity and fluctuations in manufacturing yields;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes or fluctuations in customer order patterns and seasonality;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in tax regulations in countries in which we do business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• new accounting pronouncements or changes in existing accounting standards and practices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• levels of inventories held by our customers and the customers of our distributors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risk of excess and obsolete inventories;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• competitive developments including pricing pressures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• unauthorized copying of our products resulting in pricing pressure and loss of sales;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully transition to more advanced process technologies to reduce manufacturing costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the level of orders that are received and can be shipped in a quarter, including the impact of product lead times;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the level of sell-through of our products through distribution;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to continue to realize the expected benefits of our past or future acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fluctuations in our mix of product sales;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• announcements of other significant acquisitions by us or our competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• costs and outcomes of any current or future tax audits or any litigation, investigation or claims involving intellectual property, our Microsemi acquisition, customers or other issues; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• property damage or other losses, whether or not covered by insurance.

Period-to-period comparisons of our operating results are not necessarily meaningful and you should not rely upon any such comparisons as indications of our future performance. In future periods, our operating results may fall below our public guidance or the expectations of public market analysts and investors, which would likely have a negative effect on the price of our common stock. Uncertain global economic and public health conditions, such as the COVID-19 pandemic, have caused and may in the future cause our operating results to fluctuate significantly and make comparisons between periods less meaningful.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

***Our operating results may be adversely impacted if economic conditions impact the financial viability of our licensees, customers, distributors, or suppliers.***

We regularly review the financial performance of our licensees, customers, distributors and suppliers. Any downturn in global or regional economic conditions, as a result of rising interest rates, high inflation, the COVID-19 pandemic, the enactment of broad sanctions by the U.S. or other countries against Russia, or other factors, may adversely impact their financial viability. The financial failure of a large licensee, customer or distributor, an important supplier, or a group thereof, could have an adverse impact on our operating results and could result in our inability to collect our accounts receivable balances, higher allowances for credit losses, and higher operating costs as a percentage of net sales.

***We may lose sales if suppliers of raw materials, components or equipment fail to meet our or our customers' needs, increase prices or are impacted by increases in tariffs.***

Our manufacturing operations require raw and processed materials and equipment that must meet exacting standards. We generally have multiple sources for these supplies, but there may be a limited number of suppliers capable of meeting our standards. We have experienced supply shortages from time to time in the past, and on occasion our suppliers have told us they need more time to fill our orders, that they cannot fill certain orders, that they will no longer support certain equipment with updates or parts, or that they are increasing prices. In particular, in the first nine months of fiscal 2023 and in fiscal 2022, we experienced increased prices at certain suppliers for certain materials required for production purposes. Such conditions are expected to continue. An interruption of any materials or equipment sources, or the lack of supplier support for a particular piece of equipment, could harm our business. The supplies necessary for our business could become more difficult to obtain as worldwide use of semiconductors increases, or due to supply chain disruptions, trade restrictions or political instability. Additionally, consolidation in our supply chain due to mergers and acquisitions may reduce the number of suppliers or change our relationships with them. Also, the reduced availability of necessary labor, the impact of the COVID-19 pandemic, or the application of sanctions, trade restrictions or tariffs by the U.S. or other countries may adversely impact the industry supply chain. For example, in 2019, the U.S. government increased tariffs on U.S. imports with China as their country of origin. Likewise, the China government increased tariffs on China imports with U.S. as their country of origin. We have taken steps to attempt to mitigate the costs of these tariffs on our business. Although these increases in tariffs did not significantly increase the operating costs of our business, they did, however, adversely impact demand for our products during fiscal 2020 and fiscal 2019. The additional tariffs imposed on components or equipment that we or our suppliers source from China will increase our costs and could have an adverse impact on our operating results in future periods. We may also incur increases in manufacturing costs in mitigating the impact of tariffs on our operations. This could also impair sourcing flexibility.

Our customers may also be adversely affected by these same issues. The labor, supplies and equipment necessary for their businesses could become more difficult to obtain for various reasons not limited to business interruptions of suppliers, reduced availability of labor, consolidation in their supply chain, the impact of the COVID-19 pandemic, or sanctions, trade restrictions or tariffs that impair sourcing flexibility or increase costs. If our customers are not able to produce their products, then their need for our products will decrease. Such interruptions of our customers' businesses could harm our business.

We do not purchase significant amounts of equipment from Russia, Belarus, or Ukraine. However, the semiconductor industry, and purchasers of semiconductors, use raw materials that are sourced from these regions, such as neon, palladium, cesium, rubidium, and nickel. If we, or our direct or indirect customers, are unable to obtain the requisite raw materials or components needed to manufacture products, our ability to manufacture products, or demand for our products, may be adversely impacted. This could have a material adverse effect on our business, results of operations or financial condition. While there has been an adverse impact on the world's palladium, neon, cesium, and rubidium supply chains, at this time, our supply chains have been able to meet our needs. While sales of our products into the regions, and to customers that sell into these regions, have been negatively impacted by the Russian invasion of Ukraine, at this time, we have not experienced a material impact on our business, results of operations or financial conditions.

***We are dependent on wafer foundries and other contractors, as are our SuperFlash and other licensees.***

We rely on outside wafer foundries for a significant portion of our wafer fabrication needs. Specifically, during the first nine months of fiscal 2023, approximately 63% of our net sales came from products that were produced at outside wafer foundries compared to 60% of our net sales in fiscal 2022. We also use several contractors for a portion of the assembly and testing of our products. Specifically, during the first nine months of fiscal 2023, approximately 41% of our assembly requirements and 33% of our test requirements were performed by third party contractors, compared to approximately 41% and 36%, respectively, during fiscal 2022. Due to increased demand for our products, we have taken actions in recent

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

quarters to increase our capacity allocation from our wafer fabrication, assembly and test subcontractors. However, we expect foundry capacity to continue to be limited for certain process technology nodes and there can be no assurance that we will be able to secure the necessary allocation of capacity from our wafer foundries and other contractors, that any such additional capacity will have the ability to manufacture the process technologies that we need, or that such capacity will be available on acceptable terms. Although we are continuing to expand our internal wafer fabrication, assembly and test capacity, we expect that our reliance on third-party contractors may increase over time as our business grows, and any inability to secure necessary external capacity could adversely affect our operating results.

As our manufacturing subcontractors move to more advanced process technologies over time, we may find that they do not invest in some of the trailing edge process technologies on which a large portion of our products are manufactured. If this occurs, it may limit the amounts of net sales that we can achieve or require us to make significant investments to be able to manufacture these products in our own existing facilities, at new facilities or at other foundries and assembly and testing contractors. In August 2022, the U.S. government passed the CHIPS Act to provide billions of dollars of cash incentives and a new investment tax credit to increase domestic manufacturing capacity in our industry. Such incentives may potentially be available to us, our competitors and foundries; however, there can be no assurance as to which companies will receive such incentives and whether the legislation will have a positive or negative impact on our competitive position.

Our use of third parties reduces our control over the subcontracted portions of our business. Our future operating results could suffer if a significant contractor were to experience production difficulties, insufficient capacity, decreased manufacturing, reduced availability of labor, assembly and test yields, or increased costs due to disruptions from the COVID-19 pandemic, political upheaval or infrastructure disruption. Additionally, our future operating results could suffer if our wafer foundries and other contractors increase the prices of the products and services that they provide to us. If third parties do not timely deliver products or services in accordance with our quality standards, we may be unable to qualify alternate manufacturing sources in a timely manner or on favorable terms, or at all. Additionally, these subcontractors could abandon processes that we need, or fail to adopt technologies that we desire to control costs. In such event, we could experience an interruption in production, an increase in manufacturing costs or a decline in product reliability, and our business and operating results could be adversely affected. Further, use of subcontractors increases the risks of misappropriation of our intellectual property.

Certain of our SuperFlash and other technology licensees rely on wafer foundries. If our licensees experienced disruption in supply at such foundries, this would reduce the revenue from our technology licensing business and would harm our operating results.

***We are highly dependent on foreign sales, suppliers, and operations, which exposes us to foreign political and economic risks.***

Sales to foreign customers account for a substantial portion of our net sales. During the first nine months of fiscal 2023, approximately 77% of our net sales were made to foreign customers, including 22% in China and 15% in Taiwan. During fiscal 2022, approximately 78% of our net sales were made to foreign customers, including 22% in China and 15% in Taiwan.

A strong position in the Chinese market is a key component of our global growth strategy. Although our sales in the Chinese market were very strong in calendar 2021, competition in China is intense, and China's economic growth slowed in calendar 2022 and into calendar 2023. In the past, economic weakness in the Chinese market adversely impacted our sales volumes in China. As discussed above, the trade relationship between the U.S. and China remains challenging, economic conditions in China remain uncertain, and we are unable to predict whether such uncertainty will continue or worsen in future periods. Additionally, over the last year, the impact of unpredictable COVID-19 related lockdowns and the adverse impact of the rapid transmission of COVID-19 when lock-downs in China were lifted has adversely impacted Chinese customers and the supply chain. Weakening of foreign markets could result in lower demand for our products, which could have a material adverse effect on our business, results of operations or financial conditions.

We purchase a substantial portion of our raw materials and equipment from foreign suppliers. In addition, we own product assembly and testing facilities, and finished goods warehouses near Bangkok, Thailand, which has experienced periods of political instability and severe flooding in the past. There can be no assurance that any future flooding or political instability in Thailand would not have a material adverse impact on our operations. We have a test facility in Calamba, Philippines. We use foundries and other foreign contractors for a significant portion of our assembly and testing and wafer fabrication requirements.

We do not have significant sales or operations in Russia, Belarus, or Ukraine, and we do not purchase significant amounts of equipment from these regions. However, the semiconductor industry, and purchasers of semiconductors, use raw

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

materials that are sourced from these regions, such as neon, palladium, cesium, rubidium and nickel. If we, or our direct or indirect customers, are unable to obtain the requisite raw materials or components needed to manufacture products, our ability to manufacture products, or demand for our products, may be adversely impacted. This could have a material adverse effect on our business, results of operations or financial condition. While there has been an adverse impact on the world's palladium, cesium, rubidium, and neon supply chains due to the Russia Ukraine conflict, at this time, our supply chains have been able to meet our needs. While sales of our products into the regions impacted by the Russia Ukraine conflict, and to customers that sell into these regions, have been negatively impacted by the Russian invasion of Ukraine, at this time, we have not experienced a material impact on our business, results of operations or financial condition.

Our reliance on foreign operations, foreign suppliers, maintenance of substantially all of our finished goods inventory at foreign locations and significant foreign sales exposes us to foreign political and economic risks, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• economic uncertainty in the worldwide markets served by us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• political, social and economic instability due to the COVID-19 pandemic, wars, or other factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• trade restrictions and changes in tariffs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• supply chain disruptions or delays;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• potentially adverse tax consequences;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• import and export license requirements and restrictions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in laws related to taxes, environmental, health and safety, technical standards and consumer protection;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• currency fluctuations and foreign exchange regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in staffing and managing international operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• employment regulations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disruptions due to cybersecurity incidents;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disruptions in international transport or delivery;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• public health conditions (including viral outbreaks such as COVID-19); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in collecting receivables and longer payment cycles.

If any of these risks occur or are worse than we anticipate, our sales could decrease and our operating results could suffer, we could face an increase in the cost of components, production delays, business interruptions, delays in obtaining export licenses, tariffs and other restrictions, longer payment cycles, increased taxes, restrictions on the repatriation of funds and the burdens of complying with a variety of foreign laws, any of which could ultimately have a material adverse effect on our business. Further changes in trade policy, tariffs, additional taxes, or restrictions on supplies, equipment, and raw materials including rare earth minerals, may limit our ability to produce products, increase our selling and/or manufacturing costs, decrease margins, reduce the competitiveness of our products, or inhibit our ability to sell products or purchase necessary equipment and supplies, which could have a material adverse effect on our business, results of operations, or financial conditions.

***We depend on orders that are received and shipped in the same quarter and have limited visibility to product shipments other than orders placed under our Preferred Supply Program and under our long-term supply agreements.***

Our net sales in any given quarter depend upon a combination of shipments from backlog, and orders that are both received and shipped in the same quarter, which we call turns orders. We measure turns orders at the beginning of a quarter based on the orders needed to meet the shipment targets that we set entering the quarter. Historically, our ability to respond quickly to customer orders has been part of our competitive strategy, resulting in customers placing orders with relatively short delivery schedules. Shorter lead times generally mean that turns orders as a percentage of our business are relatively high in any particular quarter and reduce our visibility on future shipments. Turns orders correlate to overall semiconductor industry conditions and product lead times. Although our backlog has been strong in recent periods due to favorable industry conditions and the impact of our Preferred Supply Program and our long-term supply agreements, in the future we expect turns orders to remain important to our ability to meet our business objectives. Because turns orders can be difficult to predict, especially in times of economic volatility where customers may change order levels within the quarter, varying levels of turns orders make it more difficult to forecast net sales. The level of turns orders may also decrease in periods where customers are holding excess inventory of our products. Our customers may have increased their order levels in previous periods to help ensure they have sufficient inventory of our products to meet their needs, or they may have been unable to sell their products at their forecasted levels. As a significant portion of our products are manufactured at foundries, foundry lead times may affect our ability to satisfy certain turns orders. If we do not achieve a sufficient level of turns orders in a particular quarter relative to our revenue targets or effectively manage our production based on changes in order forecasts, our revenue and operating results will likely suffer.

In February 2021, we announced our Preferred Supply Program and, starting in the first quarter of calendar 2022, we

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

began entering into long-term supply agreements, which offer our customers the ability to receive prioritized capacity. To participate in the Preferred Supply Program, customers have to place 12 months of orders, which cannot be cancelled or rescheduled except in the event of price increases. The capacity priority under the Preferred Supply Program began for shipments in July 2021. The Preferred Supply Program and the long-term supply agreements are not a guarantee of supply; however, they will provide the highest priority for those orders which are under these programs, and the capacity priority will be on a first-come, first-served basis until the available capacity is booked. A significant portion of our capacity is booked under these programs. We believe these programs will enable us to be in a stronger position to make capacity and raw material commitments to our suppliers, buy capital equipment with confidence, hire employees and ramp up manufacturing and manufacture products more efficiently. Since these are new programs, there can be no assurance that the programs will be successful or that they will benefit our business. In the event that customers under these programs attempt to cancel or reschedule orders, we may have to take legal or other action to enforce the terms of the programs, and any such actions could result in damage to our customer relationships or cause us to incur significant costs. Additionally, as orders under these programs cannot be cancelled or returned except in the event of price increases, these programs may result in customers holding excess inventory of our products and thus decrease their need to place new orders in later periods.

***Intense competition in the markets we serve may lead to pricing pressures, reduced sales or reduced market share.***

The semiconductor industry is intensely competitive and faces price erosion and rapid technological change. We compete with major domestic and international semiconductor companies, many of which have greater market recognition and substantially greater financial, technical, marketing, distribution and other resources than we do. The semiconductor industry has experienced significant consolidation in recent years which has resulted in several of our competitors becoming much larger in terms of revenue, product offerings and scale. We may be unable to compete successfully in the future, which could harm our business. Our ability to compete successfully depends on a number of factors, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in demand in the markets that we serve and the overall rate of growth or contraction of such markets, including but not limited to the automotive, personal computing and consumer electronics markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to obtain adequate foundry and assembly and test capacity and supplies at acceptable prices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to ramp production and increase capacity, at our wafer fabrication and assembly and test facilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the quality, performance, reliability, features, ease of use, pricing and diversity of our products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our success in designing and manufacturing new products including those implementing new technologies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the rate at which customers incorporate our products into their applications and the success of such applications;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the rate at which the markets that we serve redesign and change their own products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• product introductions by our competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the number, nature and success of our competitors in a given market;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to protect our products and processes by effective utilization of intellectual property rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to address the needs of our customers; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• general market and economic conditions.

Historically, average selling prices in the semiconductor industry decrease over the life of a product. The average selling prices of our microcontroller, FPGA products, and proprietary products in our analog product line have remained relatively constant over time, while average selling prices of our memory and non-proprietary products in our analog product line have declined over time. The overall average selling price of our products is affected by these trends; however, variations in our product and geographic mix of sales can cause wider fluctuations in our overall average selling price in any given period.

We have experienced, and may experience in the future, modest pricing declines in certain of our more mature proprietary product lines, primarily due to competitive conditions. At this time, we are not experiencing these types of pricing declines due to favorable industry conditions and demand. In the past, we have moderated average selling price declines in many of our proprietary product lines by introducing new products with more features and higher prices. However, we may not be able to do so in the future. We have experienced in the past, and may experience in the future, competitive pricing pressures in our memory and non-proprietary products in our analog product line. At this time, we are not experiencing these types of pricing declines due to favorable industry conditions and demand. In fiscal 2022, we experienced cost increases which we were able to pass on to our customers. However, in the future, we may be unable to maintain average selling prices due to increased pricing pressure, which could adversely impact our operating results.

***Our operating results will suffer if we ineffectively utilize our manufacturing capacity or fail to maintain manufacturing yields.***

Integrated circuits manufacturing processes are complex and sensitive to many factors, including contaminants in the manufacturing environment or materials used, the performance of our personnel and equipment, and other quality issues. As

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

is typical in the industry, we have from time to time experienced lower than anticipated manufacturing yields. Our operating results will suffer if we are unable to maintain yields at or above approximately the current levels. This could include delays in the recognition of revenue, loss of revenue, and penalties for failure to meet shipment deadlines. Our operating results are adversely affected when we operate below normal capacity. In the first nine months of fiscal 2023 and in fiscal 2022, we operated at or above normal capacity levels and we expect this to continue if the current supply constraints relative to demand continue.

***Our operating results are impacted by seasonality and wide fluctuations of supply and demand in the industry.***

The semiconductor industry is characterized by seasonality and wide fluctuations of supply and demand. Historically, since a significant portion of our revenue is from consumer markets and international sales, our business generates stronger revenues in the first half and comparatively weaker revenues in the second half of our fiscal year. However, broad fluctuations in our business, changes in semiconductor industry and global economic conditions (including the impact of continued strong demand in the industry, the COVID-19 pandemic or trade tensions) and our acquisition activity (including our acquisition of Microsemi) have had and can have a more significant impact on our results than seasonality. In periods when broad fluctuations, changes in business conditions or acquisitions occur, it is difficult to assess the impact of seasonality on our business. The semiconductor industry has had significant economic downturns, characterized by diminished product demand and production over-capacity. We have sought to reduce our exposure to this industry cyclicality by selling proprietary products, that cannot be quickly replaced, to a geographically diverse customer base across a broad range of market segments. However, we have experienced substantial period-to-period fluctuations in operating results and expect, in the future, to experience period-to-period fluctuations in operating results due to general industry or economic conditions.

***Our business is dependent on distributors to service our end customers.***

Sales to distributors accounted for approximately 47% of our net sales in the first nine months of fiscal 2023 and approximately 48% of our net sales in fiscal 2022. With the exception of orders placed under our Preferred Supply Program, we do not have long-term purchase agreements with our distributors, and we and our distributors may each terminate our relationship with little or no advance notice.

Future adverse conditions in the U.S. or global economies and labor markets (including the impact of the COVID-19 pandemic) or credit markets could materially impact distributor operations. Any deterioration in the financial condition, or disruption in the operations of our distributors, could adversely impact the flow of our products to our end customers and adversely impact our results of operation. In addition, during an industry or economic downturn, there may be an oversupply and decrease in demand for our products, which could reduce our net sales in a given period and increase inventory returns. Violations of the Foreign Corrupt Practices Act, or similar laws, by our distributors could have a material adverse impact on our business.

***Our success depends on our ability to introduce new products on a timely basis.***

Our future operating results depend on our ability to develop and timely introduce new products that compete effectively on the basis of price and performance and which address customer requirements. The success of our new product introductions depends on various factors, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• effective new product selection;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• timely completion and introduction of new product designs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• availability of skilled employees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• procurement of licenses for intellectual property rights from third parties under commercially reasonable terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• timely filing and protection of intellectual property rights for new product designs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• availability of development and support tools and collateral literature that make complex new products easy for engineers to understand and use; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• market acceptance of our customers' end products.

Because our products are complex, we have experienced delays from time to time in completing new product development. New products may not receive or maintain substantial market acceptance. We may be unable to timely design, develop and introduce competitive products, which could adversely impact our future operating results.

Our success also depends upon our ability to develop and implement new design and process technologies. Semiconductor design and process technologies are subject to rapid technological change and require significant R&D expenditures. We and others in the industry have, from time to time, experienced difficulties in transitioning to advanced process technologies and have suffered reduced manufacturing yields or delays in product deliveries. Our future operating

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

results could be adversely affected if any transition to future process technologies is substantially delayed or inefficiently implemented.

***Business interruptions to our operations or those of our key vendors, licensees or customers could harm our business.***

Operations at any of our facilities, at the facilities of any of our wafer fabrication or assembly and test subcontractors, or at any of our significant vendors, licensees or customers may be disrupted due to public health concerns (including outbreaks such as COVID-19), work stoppages or reduction in available labor, power loss, insufficient water, cyber attacks, computer network compromises, incidents of terrorism or security risk, political instability, telecommunications, transportation or other infrastructure failure, radioactive contamination, or fire, earthquake, floods, droughts, volcanic eruptions or other natural disasters. We have taken steps to mitigate the impact of some of these events should they occur; however, we cannot be certain that we will avoid a significant impact on our business in the event of a business interruption. For example, in the first three months of fiscal 2023 and in fiscal 2022, COVID-19 related restrictions adversely impacted our manufacturing operations in the U.S., Philippines and Thailand along with our subcontractors' manufacturing operations in Malaysia, Taiwan and China. Similar challenges arose for our logistics service providers, which adversely impacted their ability to ship product to our customers. The pandemic could adversely impact our business in future periods if the impact of COVID-19 again becomes severe in one or more of our key markets such as China or in areas where our suppliers or manufacturing operations are located. In the future, local governments could require us to reduce production, cease operations at any of our facilities, or implement mandatory vaccine requirements, and we could experience constraints in fulfilling customer orders.

Additionally, operations at our customers and licensees may be disrupted for a number of reasons. In April and May 2020, we received a greater number of order cancellations and requests by our customers to reschedule deliveries to future dates. Some customers requested order cancellations within our firm order window and claimed applicability of force majeure clauses due to the impact of COVID-19. Likewise, if our licensees are unable to manufacture and ship products incorporating our technology, or if there is a decrease in product demand due to a business disruption, our royalty revenue may decline.

Also, Thailand has experienced periods of severe flooding in recent years. While our facilities in Thailand have continued to operate normally, there can be no assurance that future flooding in Thailand would not have a material adverse impact on our operations. If operations at any of our facilities, or our subcontractors' facilities are interrupted, we may not be able to timely shift production to other facilities, and we may need to spend significant amounts to repair or replace our facilities and equipment. Business interruptions would likely cause delays in shipments of products to our customers, and alternate sources for production may be unavailable on acceptable terms. This could result in reduced revenues, cancellation of orders, or loss of customers. Although we maintain business interruption insurance, such insurance will likely not compensate us for any losses or damages, and business interruptions could significantly harm our business.

***Our technology licensing business exposes us to various risks*.** 

Our technology licensing business is based on our SuperFlash and other technologies. The success of our licensing business depends on the continued market acceptance of these technologies and on our ability to further develop such technologies and to introduce new technologies. To be successful, any such technology must be able to be repeatably implemented by licensees, provide satisfactory yield rates, address licensee and customer requirements, and perform competitively. The success of our technology licensing business depends on various other factors, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• proper identification of licensee requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• timely development and introduction of new or enhanced technology;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to protect and enforce our intellectual property rights for our licensed technology;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to limit our liability and indemnification obligations to licensees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• availability of development and support services to assist licensees in their design and manufacture of products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• availability of foundry licensees with sufficient capacity to support OEM production; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• market acceptance of our customers' end products.

Because our licensed technologies are complex, there may be delays from time to time in developing and enhancing such technologies. There can be no assurance that our existing or any enhanced or new technology will achieve or maintain substantial market acceptance. Our licensees may experience disruptions in production or reduced production levels which would adversely affect the revenue that we receive. Our technology license agreements generally include a clause that indemnifies the licensee against liability and damages (including legal defense costs) arising from certain intellectual property matters. We could be exposed to substantial liability for claims or damages related to intellectual property matters or indemnification claims. Any claim could result in significant legal fees and require significant attention from our management.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

These issues may adversely impact the success of our licensing business and adversely affect our future operating results.

***Reliance on sales into governmental projects could have a material adverse effect on our results of operations.***

A significant portion of the sales of Microsemi, which we acquired in May 2018, are from or are derived from government agencies or customers who sell to U.S. government agencies. Such sales are subject to uncertainties regarding governmental spending levels, spending priorities, regulatory and policy changes. Future sales into U.S. government projects are subject to uncertain government appropriations and national defense policies and priorities, including the budgetary process, changes in the timing and spending priorities, the impact of any past or future government shutdowns, contract terminations or renegotiations, future sequestrations, changes in regulations that we must comply with to be eligible to accept new contracts, such as the Cybersecurity Maturity Model Certification requirements and mandatory vaccine requirements, or the impact of the COVID-19 pandemic. For example, in fiscal 2022, as a result of the COVID-19 pandemic, we experienced suspensions and stop work orders for some of our subcontracts. Additionally, the amendment to the U.S. National Defense Authorization Act (NDAA) was signed into law on December 23, 2022, and its provisions go into effect in December 2027. The NDAA amendment prohibits U.S. government agencies from buying semiconductor products or services manufactured by SMIC, YMTC, CXMT and any other entity that the U.S. government determines is owned, controlled, or connected to the government of a foreign country of concern (Prohibited Companies). Some of our products are manufactured at SMIC, and some of our suppliers buy products manufactured at YMTC. If we are unable to alternately source or manufacture certain of our products, or discontinue use of products from Prohibited Companies, if any, when the NDAA amendment goes into effect in December 2027, this could adversely impact our sales to U.S. government agencies and their prime customers. Although such actions have not yet had a material adverse impact on our business, there can be no assurance as to the future costs or implications of such actions. Sales into government projects are also subject to uncertainties related to monetary, regulatory, tax and trade policies implemented by current or future administrations or by the U.S. Congress.

In the past, Microsemi has experienced delays and reductions in appropriations on programs that included its products. For example, in 2018 there were two federal government shutdowns. Further delays, reductions in or terminations of government contracts or subcontracts, including those caused by any past or future shutdown of the U.S. federal government, could materially and adversely affect our operating results. If the U.S. government fails to complete its annual budget process or to provide for a continuing resolution to fund government operations, another federal government shutdown may occur, during which we may experience further delays, reductions in or terminations of government contracts or subcontracts, which could materially and adversely affect our operating results. While we generally function as a subcontractor in these type of transactions, further changes in U.S. government procurement regulations and practices, particularly surrounding initiatives to reduce costs or increase compliance obligations (such as the Cybersecurity Maturity Model Certification and mandatory vaccine requirements), may adversely impact the contracting environment, our ability to hire and retain employees, and our operating results.

The U.S. government and its contractors may terminate their contracts with us at any time. For example, in 2014, the U.S. government terminated a $75 million contract with Microsemi. Uncertainty in government spending and termination of contracts for government related projects could have a material adverse impact on the revenue from our Microsemi acquisition. Our contracts with U.S. governmental agencies or prime customers require us to comply with the contract terms, and governmental regulations, particularly for our facilities, systems and personnel that service such customers. To be awarded new contracts, we may be required to meet certain levels of the Cybersecurity Maturity Model Certification that we may not meet, or choose to meet. Complying with these regulations, including audit requirements, requires that we devote significant resources to such matters in terms of training, personnel, information technology and facilities. Any failure to comply with these requirements may result in fines and penalties, or loss of current or future business, that may materially and adversely affect our operating results.

***From time to time we receive grants from governments, agencies and research organizations. If we are unable to comply with the terms of those grants, we may not be able to receive or recognize grant benefits or we may be required to repay grant benefits and recognize related charges, which would adversely affect our operating results and financial position.***

From time to time, we receive economic incentive grants and allowances from European governments, agencies and research organizations targeted at increasing employment at specific locations. The subsidy grant agreements typically contain economic incentive, headcount, capital and research and development expenditures and other covenants that must be met to receive and retain grant benefits, and these programs can be subjected to periodic review by the relevant governments. Noncompliance with the conditions of the grants could result in our forfeiture of all or a portion of any future amounts to be received, as well as the repayment of all or a portion of amounts received to date.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

***We may not fully realize the anticipated benefits of our completed or future acquisitions or divestitures.***

We have acquired, and expect in the future to acquire, additional businesses that we believe will complement or augment our existing businesses. In May 2018, we acquired Microsemi, which was our largest and most complex acquisition ever. Integration of our acquisitions is complex and may be costly and time consuming and include unanticipated issues, expenses and liabilities. We may not successfully or profitably integrate, operate, maintain and manage any newly acquired operations or employees. We may not be able to maintain uniform standards, procedures and policies. We may not realize the expected synergies and cost savings from the integration. There may be increased risk due to integrating financial reporting and internal control systems. It may be difficult to develop, manufacture and market the products of a newly acquired company, or grow the business at the rate we anticipate. Following an acquisition, we may not achieve the revenue or net income levels that justify the acquisition. We may suffer loss of key employees, customers and strategic partners of acquired companies and it may be difficult to implement our corporate culture at acquired companies. We have been and may in the future be subject to claims from terminated employees, shareholders of Microchip or the acquired companies and other third parties related to the transaction. In particular, in connection with our Microsemi and Atmel acquisitions, we became involved with third-party claims, litigation, governmental investigations and disputes related to such businesses and transactions. See "Note 11. Commitments and Contingencies" to our condensed consolidated financial statements for information regarding such matters which are still pending. Acquisitions may also result in charges (such as acquisition-related expenses, write-offs, restructuring charges, or future impairment of goodwill), contingent liabilities, adverse tax consequences, additional share-based compensation expense and other charges that adversely affect our operating results. To fund our acquisition of Microsemi, we used a significant portion of our cash balances and incurred approximately $8.10 billion of additional debt. We may fund future acquisitions of new businesses or strategic alliances by utilizing cash, borrowings under our Revolving Credit Facility, raising debt, issuing shares of our common stock, or other mechanisms.

Further, if we decide to divest assets or a business, it may be difficult to find or complete divestiture opportunities or alternative exit strategies, which may include site closures, timely or on acceptable terms. These circumstances could delay the achievement of our strategic objectives or cause us to incur additional expenses with respect to the desired divestiture, or the price or terms of the divestiture may be less favorable than we had anticipated. Even following a divestiture or other exit strategy, we may have certain continuing obligations to former employees, customers, vendors, landlords or other third parties. We may also have continuing liabilities related to former employees, assets or businesses. Such obligations may have a material adverse impact on our results of operations and financial condition.

In addition to acquisitions, we have in the past, and expect in the future, to enter into joint development agreements or other strategic relationships with other companies. These transactions are subject to a number of risks similar to those we face with our acquisitions including our ability to realize the expected benefits of any such transaction, to successfully market and sell products resulting from such transactions or to successfully integrate any technology developed through such transactions.

***As a result of our acquisition activity, including our acquisition of Microsemi in May 2018, our goodwill and intangible assets increased significantly and we may in the future incur impairments to goodwill or intangible assets.*** 

When we acquire a business, a substantial portion of the purchase price of the acquisition is allocated to goodwill and other identifiable intangible assets. The amount of the purchase price which is allocated to goodwill is determined by the excess of the purchase price over the net identifiable assets acquired. As of December 31, 2022, we had goodwill of $6.67 billion and net intangible assets of $3.54 billion. In connection with the completion of our acquisition of Microsemi in May 2018, our goodwill and intangible assets increased significantly. We review our indefinite-lived intangible assets, including goodwill, for impairment annually in the fourth fiscal quarter or whenever events or changes in circumstances indicate that the carrying amount of those assets is more likely than not impaired. Factors that may be considered in assessing whether goodwill or intangible assets may be impaired include a decline in our stock price or market capitalization, reduced estimates of future cash flows and slower growth rates in our industry. Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on experience and to rely heavily on projections of future operating performance. Because we operate in highly competitive environments, projections of our future operating results and cash flows may vary significantly from our actual results. No goodwill impairment charges were recorded in the first nine months of fiscal 2023 or in fiscal 2022. We recognized $1.4 million of intangible asset impairment charges in the first nine months of fiscal 2023. No intangible asset impairment charges were recorded in the first nine months of fiscal 2022. If in future periods, we determine that our goodwill or intangible assets are impaired, we will be required to write down these assets which would have a negative effect on our condensed consolidated financial statements.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

***If we fail to maintain proper and effective internal control and remediate any future control deficiencies, our ability to produce accurate and timely financial statements could be impaired, which could harm our operating results, our ability to operate our business and our reputation with investors.***

We have in the past identified a material weakness in our internal controls related to accounting for income taxes and we also identified a material weakness in our internal controls related to IT system access. Although such material weaknesses were remediated in fiscal 2020, there can be no assurance that similar control issues will not be identified in the future. If we cannot remediate future material weaknesses or significant deficiencies in a timely manner, or if we identify additional control deficiencies that individually or together constitute significant deficiencies or material weaknesses, our ability to accurately record, process, and report financial information and our ability to prepare financial statements within required time periods, could be adversely affected. Failure to maintain effective internal controls could result in violations of applicable securities laws, stock exchange listing requirements, and the covenants under our debt agreements, subject us to litigation and investigations, negatively affect investor confidence in our financial statements, and adversely impact our stock price and our ability to access capital markets.

Ensuring that we have adequate internal financial and accounting controls and procedures so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. GAAP. We are required to comply with Section 404 of the Sarbanes-Oxley Act of 2002 which requires an annual management assessment of the effectiveness of our internal control over financial reporting and a report by our independent auditors. In addition to the identified material weaknesses related to accounting for income taxes and to IT system access, which were remediated as of March 31, 2020, we have from time to time identified other significant deficiencies. If we fail to remediate any future material weaknesses or significant deficiencies or to maintain proper and effective internal control over financial reporting in the future, our ability to produce accurate and timely financial statements could be impaired, which could harm our operating results, harm our ability to operate our business and reduce the trading price of our stock.

***Customer demands for us to implement business practices that are more stringent than legal requirements may reduce our revenue opportunities or cause us to incur higher costs.***

Some of our customers require that we implement practices that are more stringent than those required by applicable laws with respect to labor requirements, the materials contained in our products, energy efficiency, environmental matters or other items. To comply with such requirements, we also require our suppliers to adopt such practices. Our suppliers may in the future refuse to implement these practices, or may charge us more for complying with them. If certain of our suppliers refuse to implement the practices, we may be forced to source from alternate suppliers. The cost to implement such practices may cause us to incur higher costs and reduce our profitability, and if we do not implement such practices, such customers may disqualify us as a supplier, resulting in decreased revenue opportunities. Developing, enforcing, and auditing customer-requested practices at our own sites and in our supply chain will increase our costs and may require more personnel.

***We must attract and retain qualified personnel to be successful, and competition for qualified personnel has intensified.***

We must attract and retain qualified personnel to be successful, and competition for qualified personnel has intensified in recent periods in our industry due to high demand for skilled employees. Availability of labor is currently constrained in certain geographic markets in which we operate due to the tight and competitive labor market in our industry. Competition for available labor has intensified for a variety of reasons, including the increase in work-from home arrangements brought about by COVID-19, and the wage inflation in our industry. We expect labor conditions will likely intensify further due to the expected construction of new wafer fabrication facilities by foundries and third parties in locations near our existing facilities.

Our ability to attract and retain skilled employees such as management, technical, marketing, sales, research and development, manufacturing, and operational personnel is critical to our business. We rely on a direct labor force at our manufacturing facilities. Any inability to maintain our labor force at our facilities may disrupt our operations, delay production, shipments and revenue and result in us being unable to timely satisfy customer demand, and ultimately could materially and adversely affect our business, financial condition and results of operations. Our inability to attract and retain hardware and software engineers and sales and marketing personnel, could delay the development and introduction of, and harm our ability to sell, our products. We have no employment agreements with any member of our senior management team, and it is possible that they could leave with little or no notice, which could make it more difficult for us to execute our planned business strategy. Our inability to retain, attract or motivate personnel could have a material adverse effect on our business, financial condition and results of operations.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

***The occurrence of events for which we are self-insured, or which exceed our insurance limits, may adversely affect our profitability and liquidity.***

We have insurance coverage related to many different types of risk; however, we self-insure for some potentially significant risks and obligations, because we believe that it is more cost effective for us to self-insure than to pay the high premium costs. The risks and exposures that we self-insure include, but are not limited to, employee health matters, certain property matters, product defects, cybersecurity matters, employment risks, environmental matters, political risks, and intellectual property matters. Should there be a loss or adverse judgment in an area for which we are self-insured, then our financial condition, results of operations and liquidity may be materially adversely affected.

**Risks Related to Cybersecurity, Privacy, Intellectual Property, and Litigation**

***We continue to be the target of attacks on our IT systems. Interruptions in and unauthorized access to our IT systems, our products, or our improper handling of data, could adversely affect our business.***

We rely on the uninterrupted operation of complex IT systems and networks to operate our business. Any significant disruption to our systems or networks, including, but not limited to, new system implementations, computer viruses, security breaches, facility issues, natural disasters, terrorism, war, telecommunication failures or energy blackouts could have a material adverse impact on our business, operations, supply chain, sales and operating results. Such disruption could result in an unauthorized release of our, our suppliers' or our customers' intellectual property or confidential, proprietary or sensitive information, or the release of personal data. Any release of such information or data could harm our business or competitive position, result in a loss of customer confidence, and cause us to incur significant costs to remedy the damages. In addition, any release of such information or data or the failure to properly manage the collection, handling, transfer or disposal of such information may result in regulatory inquiries or penalties, enforcement actions, remediation obligations, claims for damages, litigation, and other sanctions.

We have experienced verifiable attacks on our IT systems and data, including network compromises, attempts to breach our security measures and attempts to introduce malicious software into our IT systems. For example, in fiscal 2019, we learned of an ongoing compromise of our computer networks by what is believed to be sophisticated hackers. We engaged outside legal counsel and a leading forensic investigatory firm with experience in such matters. We took steps to identify malicious activity on our network including a compromise of our network and, in May 2019, we began implementing a containment plan. We routinely evaluate the effectiveness of the containment mechanisms that were implemented and continue to implement additional measures. We have analyzed the information that was compromised. We do not believe that this IT system compromise has had a material adverse effect on our business or resulted in any material damage to us. As a result of the IT system compromise, our management, including our chief executive officer and our chief financial officer, concluded that our internal controls related to IT system access were not effective resulting in a material weakness in our internal controls for fiscal 2019. Although this material weakness in our internal control was remediated in fiscal 2020, there can be no assurance that similar control issues will not be identified in future periods.

Due to the types of products we sell and the significant amount of sales we make to government agencies or customers whose principal sales are to U.S. government agencies, we have experienced and expect to continue to experience in the future, attacks on our IT systems and data, including attempts to breach our security, network compromises and attempts to introduce malicious software into our IT systems. Were any future attacks to be successful, we may be unaware of the incident, its magnitude, or its effects until significant harm is done. In recent years, we have regularly implemented improvements to our protective measures which include, but are not limited to, implementation of the following: firewalls, endpoint intrusion detection and response software, regular patches, log monitors, event correlation tools, network segmentation, routine backups with offsite retention of storage media, system audits, dual factor identification, data partitioning, privileged account segregation and monitoring, routine password modifications, and an enhanced information security program including training classes and phishing exercises for employees and contractors with system access, along with tabletop exercises conducted by information security personnel. As a result of the material weakness in our internal controls resulting from the IT systems compromise in fiscal 2019, we have taken remediation actions and implemented additional controls and we are continuing to take actions to attempt to address evolving threats. However, recent system improvements have not been fully effective in preventing attacks on our IT systems and data, including breaches of our security measures, and there can be no assurance that any future system improvements will be effective in preventing future cyber-attacks or disruptions or limiting the damage from any future cyber-attacks or disruptions. Such system improvements have resulted in increased costs to us and any future improvements, attacks or disruptions could result in additional costs related to rebuilding our internal systems, defending litigation, complaints or other claims, providing notices to regulatory

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

agencies or other third parties, responding to regulatory actions, or paying damages. Such attacks or disruptions could have a material adverse impact on our business, operations and financial results.

Our products, or IP that we purchase or license from third parties for use in our products, as well as industry-standard specifications that we implement in our products, may be subject to security vulnerabilities. Our products are being used in application areas that create new or increased cybersecurity, privacy or safety risks including applications that gather and process data, such as the cloud or Internet of Things, and automotive applications. We, our customers, and the users of our products may not promptly learn of or have the ability to fully assess the magnitude or effects of a vulnerability, including the extent, if any, to which a vulnerability has been exploited. Security vulnerabilities and any limitations of, or adverse effects resulting from, mitigation techniques can adversely affect our results of operations, financial condition, sales, customer relationships, share price, prospects, and reputation in a number of ways, any of which may be material. Adverse publicity about security vulnerabilities or mitigations could damage our reputation with customers or users and reduce demand for our products and services. These effects may be greater to the extent that competing products are not susceptible to the same vulnerabilities or if vulnerabilities can be more effectively mitigated in competing products. Moreover, third parties can release information regarding potential vulnerabilities of our products before mitigations are available. This, in turn, could lead to attempted or successful exploits of vulnerabilities, adversely affect our ability to introduce mitigations, or otherwise harm our business and reputation.

Third-party service providers, such as wafer foundries, assembly and test contractors, distributors, credit card processors and other vendors have access to portions of our and our customers' data. In the event that these service providers do not properly safeguard the data that they hold, security breaches and loss of data could result. Any such breach or loss of data by our third-party service providers could negatively impact our business, operations and financial results, as well as our relationship with our customers.

***Our failure to comply with federal, state, or international privacy and data protection laws and regulations may materially adversely affect our business, results of operations and financial condition.***

We are subject to numerous laws and regulations in the U.S. and internationally regarding privacy and data protection such as the European Union's (EU) General Data Protection Regulation (GDPR), the U.K. equivalent to the GDPR, the California Consumer Privacy Act, and the California Privacy Rights Act. The scope of these laws and regulations is rapidly evolving, subject to differing interpretations, and may be inconsistent among jurisdictions. Some of these laws create a broad definition of personal information, establish data privacy rights, impose data breach notification requirements, and create potentially severe statutory damages frameworks and private rights of action for certain data breaches. Some of the laws and regulations also place restrictions on our ability to collect, store, use, transmit and process personal information and other data across our business. For example, the GDPR restricts the ability of companies to transfer personal data from the European Economic Area (EEA) to the U.S. and other countries. Further, such laws and regulations have resulted and will continue to result in significantly greater compliance burdens and costs for companies such as us that have employees, customers, and operations in the EEA.

In order to comply with the GDPR, we have relied mainly on the European Commission's Standard Contractual Clauses (SCCs), for transfers of personal information from the EEA to the U.S. or other countries. However, the Court of Justice of the EU in a July 2020 decision (Schrems II) invalidated the EU-U.S. Privacy Shield Framework, and also called for stricter conditions in the use of the SCCs. Following the Schrems II decision, certain data protection authorities in the EU have issued statements advising companies within their jurisdiction not to transfer personal data to the U.S. under the SCCs. At present, there are few, if any, viable alternatives to the SCCs. If we are unable to implement sufficient safeguards to ensure that our transfers of personal information from the EEA are lawful, we may face increased exposure to regulatory actions and substantial fines and injunctions against processing personal information from the EEA. The loss of our ability to lawfully transfer personal data out of the EEA may cause reluctance or refusal by European customers to communicate with us as they are currently, and we may be required to increase our data processing capabilities in the EEA at significant expense. Additionally, other countries outside of the EEA have passed or are considering passing laws requiring local data residency which could increase the cost and complexity of providing our products in those jurisdictions.

Furthermore, the GDPR and the U.K. equivalent of the GDPR expose us to two parallel data protection regimes in Europe, each of which potentially authorizes fines and enforcement actions for certain violations. Substantial fines may be imposed for breaches of data protection requirements, which can be up to 4% of a company's worldwide revenue or 20 million Euros, whichever is greater. Although the U.K. data protection regime currently permits data transfers from the U.K. to the EEA and other third countries, covered by a European Commission 'adequacy decision' through the continued use of SCCs and binding corporate rules, these laws and regulations are subject to change, and any such changes could have adverse implications for our transfer of personal data from the U.K. to the EEA and other third countries.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

While we plan to continue to undertake efforts to conform to current regulatory obligations and evolving best practices, such efforts may be unsuccessful or result in significant costs. We may also experience reluctance, or refusal by European or multi-national customers to continue to provide us with personal data due to the potential risk exposure of personal data transfers and the current data protection obligations imposed on them by applicable data protection laws or by certain data protection authorities. These and any other data privacy laws and their interpretations continue to develop and their uncertainty and inconsistency may increase the cost of compliance, cause compliance challenges, restrict our ability to offer products in certain locations in the same way that we have been, potentially adversely affect certain third-party service providers, or subject us to sanctions by data protection regulators, all of which could adversely affect our business, financial condition and results of operations.

***We are exposed to various risks related to legal proceedings, investigations or claims.***

We are currently, and in the future may be, involved in legal proceedings, investigations or claims regarding intellectual property rights, product failures, our Microsemi acquisition, contracts and other matters. As is typical in the semiconductor industry, we receive notifications from third parties from time to time who believe that we owe them indemnification or other obligations related to claims made against us, our direct or indirect customers, or our licensees. These legal proceedings and claims, even if meritless or if they have been resolved, have in the past and could in the future result in unexpected and substantial costs to us. If we are unable to resolve or settle a matter, obtain necessary licenses on reasonable terms, reengineer products or processes to avoid infringement, provide a cost-effective remedy, or successfully prosecute or defend our position, we could incur uninsured liability in any of them, be required to take a charge to operations, be enjoined from selling a material portion of our products or using certain processes, suffer a reduction or elimination in the value of our inventories, incur reputational damage, and our business, financial condition or results of operations could be harmed.

It is also possible that from time to time we may be subject to claims related to the manufacture, performance, or use of our products. These claims may be due to injuries, economic damage or environmental exposures related to manufacturing, a product's nonconformance to our or our customer's specifications, changes in our manufacturing processes, or unexpected customer system issues due to the integration of our products or insufficient design or testing by our customers. We could incur significant expenses related to such matters, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• costs related to writing off the value of our inventory of nonconforming products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• recalling nonconforming products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• providing support services, product replacements, or modifications to products and the defense of such claims;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• diversion of resources from other projects;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• lost revenue or a delay in the recognition of revenue due to cancellation of orders or unpaid receivables;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• customer imposed fines or penalties for failure to meet contractual requirements; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a requirement to pay damages, penalties or recall costs.

Because the systems into which our products are integrated have a higher cost of goods than the products we sell, the expenses and damages we are asked to pay may be significantly higher than the revenue and profits we received. While we exclude consequential damages in our standard terms and conditions, certain of our contracts may not exclude such liabilities. Further, our ability to avoid such liabilities may be limited by law. We have liability insurance which covers certain damages arising out of product defects, but we do not expect that insurance will fully protect against such claims. Payments we may make in connection with these customer claims may adversely affect the results of our operations.

Further, we sell to customers in industries such as automotive, aerospace, defense, safety, security, and medical, where failure of the application could cause damage to property or persons. We may be subject to claims if our products, or the integration of our products, cause system failures. We will face increased exposure to claims if there are substantial increases in either the volume of our sales into these applications or the frequency of system failures integrating our products.

***Our contractual relationships with our customers expose us to risks and liabilities.***

With the exception of orders placed under our Preferred Supply Program and long-term supply agreements, we do not typically enter into long-term contracts with our non-distributor customers, and therefore we cannot be certain about future order levels from our customers. When we enter into customer contracts (other than under our Preferred Supply Program and long-term supply agreements), the contracts are generally cancelable based on standard terms and conditions. Under our Preferred Supply Program and long-term supply agreements, customers may cancel contracts in the event of price increases. While we had approximately 125,000 customers, and our ten largest direct customers accounted for approximately 12% of our total revenue in the first nine months of fiscal 2023, and four of our top ten direct customers are contract manufacturers that perform manufacturing services for many customers, cancellation of customer contracts could have an

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

adverse impact on our revenue and profits. For example, due to uncertainty related to the COVID-19 pandemic, we experienced an increase in order cancellations and requests to reschedule deliveries to future dates in the first quarter of fiscal 2021.

Certain customer contracts differ from our standard terms of sale. For some of the markets that we sell into, such as the automotive and personal computer markets, our customers may have negotiating leverage over us as a result of their market size. For example, under certain contracts we have committed to supply products on scheduled delivery dates, or extended our obligations for liabilities such as warranties or indemnification for quality issues or intellectual property infringement. If we are unable to supply the customer as contractually required, the customer may incur additional production costs, lost revenues due to delays in their manufacturing schedule, or quality-related issues. We may be liable for costs and damages associated with customer claims, and we may be obligated to defend the customer against claims of intellectual property infringement and pay associated legal fees. While we try to minimize the number of contracts which contain such provisions, manage the risks of such liabilities, and set caps on our liability exposure, sometimes we are unable to do so. In order to win important designs, avoid losing business to competitors, maintain existing business, or be permitted to bid on new business, we have, and may in the future, have to agree to uncapped liability for such items as intellectual property infringement or product failure, or have to agree to liquidated damage provisions. This exposes us to risk of liability far exceeding the purchase price of the products sold under such contracts, the lifetime revenues we receive under such contracts, or potential consequential damages. Further, where we do not have negotiated customer contracts, our customer's order terms may govern the transaction and contain terms unfavorable to us. These risks could result in a material adverse impact on our results of operations and financial condition.

***Failure to adequately protect our intellectual property could result in lost revenue or market opportunities.***

Our ability to obtain patents, licenses and other intellectual property rights covering our products and manufacturing processes is important for our success. To that end, we have acquired certain patents and licenses and intend to continue to seek patents on our technology and manufacturing processes. The process of seeking patent protection can be expensive, and patents may not be issued from currently pending or future applications. In addition, our existing and new patents, trademarks and copyrights that are issued may not have sufficient scope or strength to provide meaningful protection or commercial advantage to us. We may be subject to, or may initiate, interference proceedings in the U.S. Patent and Trademark Office, patent offices of a foreign country or U.S. or foreign courts, which can require significant financial resources. In addition, the laws of certain foreign countries do not protect our intellectual property rights to the same extent as the laws of the U.S. Infringement of our intellectual property rights by a third-party could result in uncompensated lost market and revenue opportunities for us. Although we continue to aggressively defend and protect our intellectual property on a worldwide basis, there can be no assurance that we will be successful.

**Risks Related to Taxation, Laws and Regulations** 

***Our reported financial results may be adversely affected by new accounting pronouncements or changes in existing accounting standards and practices.***

We prepare our financial statements in conformity with U.S. GAAP. These accounting principles are subject to interpretation or changes by the FASB and the SEC. New accounting pronouncements and interpretations of accounting standards and practices have occurred in the past and are expected to occur in the future. New accounting pronouncements or a change in the interpretation of accounting standards or practices may have a significant effect on our reported financial results and may affect our reporting of transactions completed before the change is effective.

***Regulatory authorities in jurisdictions into or from which we ship our products or import supplies could issue new export controls or trade sanctions, levy fines, restrict or delay our ability to export products or import supplies, or increase costs associated with the manufacture or transfer of products.***

A significant portion of our sales require export and import activities. Our U.S.-manufactured products or products based on U.S. technology are subject to laws and regulations on international trade, including but not limited to the Foreign Corrupt Practices Act, EAR, International Traffic in Arms Regulations and trade sanctions against embargoed countries and denied entities, including those administered by the U.S. Departments of Commerce or Treasury, or Office of Foreign Assets Control. Licenses or license exceptions are required for the shipment of our products to certain countries. Our inability to timely obtain a license, for any reason, including a delay in license processing due to a federal government shutdown like that which occurred in 2018, or changes in government policies of approval or denial of licenses, could cause a delay in scheduled shipments which could have a material adverse impact on our revenue within the quarter of a shutdown, and in following quarters depending on the extent that license processing is delayed. Further, determination by a government that we have

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

failed to comply with trade regulations or anti-bribery regulations can result in penalties which may include denial of export privileges, fines, penalties, and seizure of products, or loss of reputation, any of which could have a material adverse effect on our business, sales and earnings. A change in laws and regulations could restrict our ability to transfer product to previously permitted countries, customers, distributors or others. For example, in October 2022, the U.S. Commerce Department published an interim final rule entitled "Implementation of Additional Export Controls: Certain Advanced Computing and Semiconductor Manufacturing Items; Supercomputer and Semiconductor End Use; Entity List Modification." This regulation imposes restrictions on advanced computing integrated circuits (ICs), computer commodities that contain such ICs, as well as on certain semiconductor manufacturing items, and expands controls on transactions involving items for supercomputer and semiconductor manufacturing end-uses, and, for example, this rule expands the scope of foreign-produced items subject to license requirements for 28 existing entities on the Entity List that are located in China. An additional example occurred in April 2018, when the U.S. Commerce Department banned U.S. companies from selling products or transferring technology to ZTE, a Chinese company, and certain subsidiaries. This ban was lifted in July 2018. In fiscal 2020, when the U.S. Commerce Department banned U.S. companies from selling products or transferring technology to certain Chinese companies, including Huawei and certain subsidiaries. In fiscal 2020, the U.S. Federal Acquisition Regulation prohibited U.S. governmental agencies from buying equipment using covered telecommunications equipment as a substantial component or critical technology where the technology came from certain Chinese companies. In July 2020, this was expanded to prohibit U.S. governmental agencies from entering into a contract with any company that uses covered telecommunications equipment whether or not the Chinese technology is related to the procurement. Effective June 2020, amendments to the EAR regarding prohibitions of sales of items with a "military end use" into China, Russia, and Venezuela, and Belarus effective March 2021, and elimination of an EAR License Exception, apply to more of our products than the previous regulations. Any of the foregoing changes could adversely impact our operational costs due to the administrative impacts of complying with these regulations, and may limit those with whom we conduct business. Any one or more of these sanctions, future sanctions, a change in laws or regulations, or a prohibition on shipment of our products or transfer of our technology to significant customers could have a material adverse effect on our business, financial condition and results of operations.

The U.S. and other countries have levied tariffs and taxes on certain goods, implemented trade restrictions, and introduced national security protection policies. Trade tensions between the U.S. and China, which escalated in 2018, have continued and include the U.S. increasing tariffs on Chinese origin goods and China increasing tariffs on U.S. origin goods. We took steps to mitigate the costs of these tariffs on our business by making adjustments in operations and supply. Although these tariff increases did not result in a material adverse impact on our operating costs in fiscal 2019 or fiscal 2020, they did reduce demand for our products during fiscal 2019 and fiscal 2020. Increased tariffs on our customers' products could adversely impact their sales, and increased tariffs on our products in comparison to those of our competitors could each result in lower demand for our products.

Further changes in trade or national security protection policy, tariffs, additional taxes, restrictions on exports or other trade barriers, may limit our ability to produce products, increase our selling and/or manufacturing costs, decrease margins, reduce the competitiveness of our products, or reduce our ability to sell products, which could have a material adverse effect on our business, results of operations or financial conditions.

***The outcome of future examinations of our income tax returns could have an adverse effect on our results of operations.***

We are subject to examination of our U.S. and certain foreign income tax returns for fiscal 2007 and later. We regularly assess the likelihood of adverse outcomes of these examinations to determine the adequacy of our provision for income taxes and have reserved for potential adjustments that may result from current or future examinations. There can be no assurance that the final determination of any of these or any future examinations will not have an adverse effect on our effective tax rates, financial position and results of operations.

***Exposure to greater than anticipated income tax liabilities, changes in tax rules and regulations, changes in the interpretation of tax rules and regulations, or unfavorable assessments from tax audits could affect our effective tax rates, financial condition and results of operations.***

We are a U.S.-based multinational company subject to tax in many U.S. and foreign jurisdictions. Our income tax obligations could be affected by many factors, including changes to our operating structure, intercompany arrangements and tax planning strategies.

Our income tax expense is computed based on tax rates at the time of the respective financial period. Our future effective tax rates, financial condition and results from operations could be unfavorably affected by changes in the tax rates in jurisdictions where our income is earned, by changes in the tax rules and regulations or the interpretation of tax rules and regulations in the jurisdictions in which we do business or by changes in the valuation of our deferred tax assets. For

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

example, the Organization for Economic Cooperation and Development has been working on a Base Erosion and Profit Shifting Project and released an implementation package in December 2022 which provides a coordinated system to ensure that multinational enterprises pay a global minimum tax. The guidelines and proposals may change aspects of the existing framework under which our tax obligations are determined in many of the countries where we do business. Similarly, the European Commission and several countries have issued proposals that would change aspects of the current tax framework under which we are taxed. These proposals include changes to the existing income tax framework, possibilities of a global minimum tax, and proposals to change or impose new types of non-income taxes, including taxes based on a percentage of revenue. In August 2022, the U.S. government enacted the Inflation Reduction Act of 2022 (Inflation Reduction Act) into law. The Inflation Reduction Act includes a new corporate alternative minimum tax (Corporate AMT) of 15% on the adjusted financial statement income (AFSI) of corporations with average AFSI exceeding $1.00 billion over a three-year period. The Corporate AMT is effective for us beginning in fiscal 2024. We are evaluating the Corporate AMT and its potential impact on our future U.S. tax expense, cash taxes, and effective tax rate.

***Our business, financial condition and operating results may be adversely impacted by policies implemented globally by the current or future administrations.***

The current administration in the U.S. and administrations in other global jurisdictions in which we operate, have indicated support for significant legislative and policy changes in areas including but not limited to tax, trade, labor, and the environment. If implemented, these changes could increase our effective tax rate, and increase our selling and/or manufacturing costs, which could have a material adverse effect on our business, results of operations or financial conditions. Changes in tax policy, trade regulations or other matters, and any uncertainty surrounding the scope or timing of such changes, could negatively impact the stock market, and reduce the trading price of our stock. For example, in February 2022, the U.S. began implementing widescale sanctions against Russia due to Russia's invasion of Ukraine. Sanctions against Belarus and certain Ukrainian regions were later implemented. Because the actions by Russia against Ukraine are in conflict with our Guiding Values, Microchip chose to cease shipments into Russia and Belarus, and we will continue to comply with applicable U.S. sanctions regarding Ukraine. While sales of our products into these regions, and to customers that sell into these regions, have been negatively impacted, at this time, we have not experienced a material adverse impact on our revenue. Retaliatory acts by Russia in response to the sanctions could include cyber attacks, sanctions, or other actions that could disrupt the economy. As a result of the foregoing risks or similar risks, the imposition of sanctions could have a material adverse effect on our business, results of operations or financial condition.

***We are subject to stringent environmental and other regulations, which may force us to incur significant expenses.***

We must comply with federal, state, local and foreign governmental regulations related to the use, storage, discharge and disposal of hazardous substances used in our products and manufacturing processes. Our failure to comply, or the failure of entities that we have acquired over time to have complied, with regulations could result in significant fines, liability for clean-up, suspension of production, cessation of operations or future liabilities. Such regulations have required us in the past, and could require us in the future, to incur significant expenses to comply with such regulations. Our failure to control the use of, or adequately restrict the discharge of, hazardous substances could impact the health of our employees and others and could impact our ability to operate. Such failure could also restrict our ability to ship certain products to certain countries, require us to modify our logistics, or require us to incur other significant costs and expenses. Environmental laws continue to expand with a focus on reducing or eliminating hazardous substances in electronic products and shipping materials. Future environmental regulations could require us to reengineer certain of our existing products and may make it more expensive for us to manufacture, sell and ship our products. In addition, the number and complexity of laws focused on the energy efficiency of electronic products, the recycling of electronic products, and the reduction in the amount and the recycling of packing materials have expanded significantly. It may be difficult for us to timely comply with these laws and we may have insufficient quantities of compliant products to meet customers' needs, thereby adversely impacting our sales and profitability. We may have to write off inventory if we hold unsaleable inventory as a result of changes to regulations. We expect these risks to continue. These requirements may increase our own costs, as well as those passed on to us by our supply chain.

***Climate change regulations and sustained adverse climate change pose risks that could harm our results of operations.***

Climate change regulations or voluntary actions we may have taken as part of our Environmental, Social, and Governance initiatives could require us to limit emissions, change manufacturing processes, substitute materials which may cost more or be less available, fund offset projects, obtain new permits or undertake other costly activities. Failure to obtain required permits could result in fines, suspension or cessation of production. Restrictions on emissions could result in significant costs such as higher energy costs, carbon taxes, and emission cap and trade programs. The cost of compliance with such regulations could restrict our manufacturing operations, increase our costs, and have an adverse effect on our operating

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

results.

In March 2022, the SEC proposed a rule entitled Enhancement and Standardization of Climate-Related Disclosures for Investors. While the proposed rule is not yet in effect and is subject to change as a result of the SEC comment process, if it were to go in effect in its current form, we would incur significant additional costs of compliance due to the need for expanded data collection, analysis, and certification. Further, certain elements of the proposed rule, such as mandatory third-party verification of emissions, may be difficult to comply with in the proposed required timeframe as there may be an insufficient number of qualified third-party verification entities to meet demand.

Sustained adverse change in climate could have a direct adverse economic impact on us, such as utility shortages, and higher costs of utilities. Certain of our operations are located in arid or tropical regions, which some experts believe may become vulnerable to fires, storms, severe floods and droughts. While our business recovery plans are intended to allow us to recover from natural disasters or other disruptive events, our plans may not protect us from all events.

***Customer demands and regulations related to conflict-free minerals may force us to incur additional expenses.***

Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, in August 2012, the SEC released investigation, and disclosure requirements regarding the use of "conflict" minerals mined from the Democratic Republic of Congo and adjoining countries. We filed a Form SD with the SEC regarding such matters on May 27, 2022. Other countries are considering similar regulations. If we cannot certify that our supply chain is free from the risk of irresponsible sourcing, customers may demand that we change the sourcing of materials used in the manufacture of our products, even if the costs for compliant materials significantly increases or availability is limited. If we change materials or suppliers, there will likely be costs associated with qualifying new suppliers and production capacity and quality could be negatively impacted. Our relationships with customers and suppliers may be adversely affected if we are unable to certify that our products are free from the risk of irresponsible sourcing. We have incurred, and expect in the future to incur, additional costs associated with complying with these disclosure requirements, such as costs related to determining the source of any conflict minerals used in our products. We may be unable to satisfy customers who require that all of the components of our products be certified as conflict free in a materially different manner than advocated by the Responsible Minerals Initiative or the Dodd-Frank Wall Street Reform and Consumer Protection Act. If we are unable to meet customer requirements, customers may disqualify us as a supplier and we may have to write off inventory if it cannot be sold.

In addition to concerns over "conflict" minerals mined from the Democratic Republic of Congo, our customers may require that other minerals and substances used within our supply chain be evaluated and reported on. An increase in reporting obligations will increase associated operating costs. This could have negative effects on our overall operating profits.

***A requirement to fund our foreign pension plans could negatively affect our cash position and operating capital.***

In connection with our acquisitions of Microsemi and Atmel, we assumed pension plans that cover certain French and German employees. Most of these plans are unfunded in compliance with statutory requirements, and we have no immediate intention of funding these plans. The projected benefit obligation totaled $74.6 million at March 31, 2022. Benefits are paid when amounts become due. We expect to pay approximately $1.6 million in fiscal 2023 for benefits earned. Should regulations require funding of these plans in the future, it could negatively affect our cash position and operating capital.

**Risks Related to Capitalization and Financial Markets**

***The future trading price of our common stock could be subject to wide fluctuations in response to a variety of factors.***

The market price of our common stock has fluctuated significantly in the recent past and is likely to fluctuate in the future. The future trading price of our common stock could be subject to wide fluctuations in response to a variety of factors, many of which are beyond our control, including, but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• global economic and financial uncertainty due to higher interest rates, higher inflation, the COVID-19 pandemic or other factors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• quarterly variations in our operating results or the operating results of other technology companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in our financial guidance or our failure to meet such guidance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in analysts' estimates of our financial performance or buy/sell recommendations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• general conditions in the semiconductor industry;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the amount and timing of repurchases of shares of our common stock;

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to realize the expected benefits of our completed or future acquisitions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• actual or anticipated announcements of technical innovations or new products by us or our competitors.

In addition, the stock market has recently and in the past experienced significant price and volume fluctuations that have affected the market prices for many companies and that often have been unrelated to their operating performance. These broad market fluctuations and other factors have harmed and may harm the market price of our common stock. The foregoing factors could also cause the market price of our Convertible Debt to decline or fluctuate substantially.

***The amount and timing of our share repurchases may fluctuate in response to a variety of factors.***

The amount, timing, and execution of repurchases of shares of our common stock may fluctuate based on the share price of our common stock, general business and market conditions, tax regulations impacting share repurchases and other factors including our operating results, level of cash flow, capital expenditures and dividend payments. Although our Board of Directors has authorized share repurchases of up to $4.00 billion, of which $2.90 billion is still available, the authorization does not obligate us to acquire any particular amount of shares. We cannot guarantee that our share repurchase authorization will be fully consummated or that it will enhance long-term shareholder value. The repurchase authorization may be suspended or discontinued at any time at our discretion and may affect the trading price of our common stock and increase volatility.

***Our financial condition and results of operations could be adversely impacted if we do not effectively manage current or future debt.***

As of December 31, 2022, the principal amount of our outstanding indebtedness was $6.62 billion. As a result of our acquisition of Microsemi, we have substantially more debt than we had prior to May 2018. At December 31, 2022, we had $253.0 million in outstanding borrowings under our Revolving Credit Facility which provides up to $2.75 billion of revolving loan commitments that terminate in 2026. At December 31, 2022, we had $5.60 billion in aggregate principal amount of Senior Notes and $766.6 million in aggregate principal of Convertible Debt outstanding.

Our maintenance of substantial levels of debt could adversely affect our ability to take advantage of opportunities and could adversely affect our financial condition and results of operations. We may need or desire to refinance our current or future debt and there can be no assurance that we will be able to do so on reasonable terms, if at all.

***Servicing our debt requires a significant amount of cash, we may not have sufficient cash to fund payments and adverse changes in our credit ratings could increase our borrowing costs and adversely affect our ability to access the debt markets.***

Our ability to make scheduled payments of principal, interest, or to refinance our indebtedness, including our outstanding Convertible Debt and Senior Notes, depends on our future performance, which is subject to economic, competitive and other factors. Our business may not continue to generate sufficient cash flow to service our debt and to fund capital expenditures, dividend payments, share repurchases or acquisitions. If we are unable to generate such cash flow, we may be required to undertake alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on onerous or highly dilutive terms. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. Our senior notes are rated by certain major credit rating agencies. These credit ratings impact our cost of borrowing and our ability to access the capital markets and are based on our financial performance and financial metrics including debt levels. There is no assurance that we will maintain our current credit ratings. A downgrade of our credit rating by a major credit rating agency could result in increased borrowing costs and could adversely affect our ability to access the debt markets to refinance our existing debt or finance future debt.

***Conversion of our Convertible Debt will dilute the ownership interest of our existing stockholders.***

The conversion of some or all of our outstanding Convertible Debt will dilute the ownership interest of our existing stockholders to the extent we deliver common stock upon conversion of such debt. Following our irrevocable settlement election made on April 1, 2022, upon conversion, we are required to satisfy our conversion obligation with respect to such converted Convertible Debt by delivering cash equal to the principal amount of such converted Convertible Debt and cash and shares of common stock or any combination, at our option, with respect to any conversion value in excess thereof (i.e., the conversion spread). There would be no adjustment to the numerator in the net income per common share computation for the cash settled portion of the Convertible Debt as that portion of the debt instrument will always be settled in cash. The conversion spread will be included in the denominator for the computation of diluted net income per common share. Any sales in the public market of any common stock issuable upon conversion of our Convertible Debt could adversely affect prevailing market prices of our common stock. In addition, the existence of the Convertible Debt may encourage short selling

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

by market participants because the conversion of the Convertible Debt could be used to satisfy short positions, or anticipated conversion of the Convertible Debt into shares of our common stock could depress the price of our common stock.

***Fluctuations in foreign currency exchange rates could adversely impact our operating results.***

We use forward currency exchange contracts in an attempt to reduce the adverse earnings impact from the effect of exchange rate fluctuations on our non-U.S. dollar net balance sheet exposures. Nevertheless, in periods when the U.S. dollar significantly fluctuates in relation to the non-U.S. currencies in which we transact business, the value of our non-U.S. dollar transactions can have an adverse effect on our results of operations and financial condition. In particular, in periods when the value of a non-U.S. currency significantly declines relative to the U.S. dollar, customers transacting in that currency may be unable to fulfill their contractual obligations or to undertake new obligations to make payments or purchase products. In periods when the U.S. dollar declines significantly relative to the British pound, Euro, Thai baht and Taiwan dollar, the operational costs in our European and Thailand subsidiaries are adversely affected. Although our business has not been materially adversely impacted by recent changes in the value of the U.S. dollar, there can be no assurance as to the future impact that any weakness or strength in the U.S. dollar will have on our business or results of operations.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

The following table sets forth our purchases of our common stock in the three months ended December 31, 2022:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Period | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced program | Approximate dollar value of shares that may yet be purchased under the program<sup>(1)</sup> (in millions) |
| October 1, 2022 - October 31, 2022 |  | $— |  | $3132.0 |
| November 1, 2022 - November 30, 2022 | 1861338 | $73.08 | 1861338 | $2996.0 |
| December 1, 2022 - December 31, 2022 | 1229799 | $76.05 | 1229799 | $2902.5 |
|  | 3091137 |  | 3091137 | $2902.5 |

---

&nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> In November 2021, our Board of Directors authorized the repurchase of up to $4.00 billion of our common stock in the open market or in privately negotiated transactions. There is no expiration date associated with this authorization.

**Item 3. Defaults Upon Senior Securities**

Not Applicable.

**Item 4. Mine Safety Disclosures**

Not Applicable.

**Item 5. Other Information**

None.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**Item 6. Exhibits** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|<br>**Exhibit Number** |<br>**Exhibit Description** | **Form** | **File Number** | **Exhibit** | **Filing Date** |<br>**Included Herewith** |
| 3.1 | <u>[Amended and Restated Certificate of Incorporation of Microchip Technology Incorporated](http://www.sec.gov/Archives/edgar/data/827054/000082705421000251/exhibit31-amendedandrestat.htm)</u> | 8-K | 000-21184 | 3.1 | August 26, 2021 |  |
| 3.2 | <u>[Amended and Restated Bylaws of Registrant, as amended effective May 25, 2021](http://www.sec.gov/Archives/edgar/data/827054/000119312521177139/d518405dex31.htm)</u> | 8-K | 000-21184 | 3.1 | May 28, 2021 |  |
| 10.1\* | <u>[Amended and Restated Form of Notice of Grant of Restricted Stock Units (Performance) for 2004 Equity Incentive Plan (including Exhibit A Performance Matrix)](ex101q3fy23.htm)</u> |  |  |  |  | X |
| 31.1 | <u>[Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended](ex311q3fy23.htm)</u> |  |  |  |  | X |
| 31.2 | <u>[Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended](ex312q3fy23.htm)</u> |  |  |  |  | X |
| 32\*\* | <u>[Certifications Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32q3fy23.htm)</u> |  |  |  |  | X |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive File because its XBRL tags are embedded within the Inline XBRL document |  |  |  |  | X |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |  |  |  |  | X |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |  |  |  |  | X |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |  |  |  |  | X |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |  |  |  |  | X |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |  |  |  |  | X |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document or included within the Exhibit 101 attachments |  |  |  |  | X |

---

&nbsp;&nbsp;&nbsp;&nbsp;\* Compensation plans or arrangements in which directors or executive officers are eligible to participate

\*\* This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing of the registrant under the Securities Act of 1933, as amended, or Securities Exchange Act of 1934, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

------

**<u>[**Table of Contents**](#i32521453983b4a318e7d58b6f396f928_4)</u>**

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | **MICROCHIP TECHNOLOGY INCORPORATED** |
| Date: | February 2, 2023 | By: <u>/s/ J. Eric Bjornholt</u>  |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;J. Eric Bjornholt |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior Vice President and Chief Financial Officer |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Duly Authorized Officer, and Principal Financial and Accounting Officer) |

---

## Exhibit 10.1

**Exhibit 10.1**

**Grant # ###**

**MICROCHIP TECHNOLOGY INCORPORATED**

**2004 EQUITY INCENTIVE PLAN**

**AMENDED AND RESTATED**

**NOTICE OF GRANT OF RESTRICTED STOCK UNITS (PERFORMANCE)**

Unless otherwise defined herein, the terms defined in the Microchip Technology Incorporated 2004 Equity Incentive Plan (the "Plan") shall have the same defined meanings in this Amended and Restated Notice of Grant of Restricted Stock Units (Performance) (the "<u>Grant Notice</u>").

**This Grant Notice supersedes and replaces the earlier notice of grant of restricted stock units (performance) that bears the same Date of Grant and Target Number of Restricted Stock Units as this Grant Notice.**

**Grantee: [NAME]**

Grantee has been granted an award of performance-based Restricted Stock Units ("<u>RSUs</u>") subject to and in accordance with the express terms and conditions of the Grant Notice (including <u>Exhibit A</u>), the Plan and the Restricted Stock Unit Agreement, including the appendix for Grantee's country, if any (the "Appendix" and together with the Restricted Stock Unit Agreement, the "Agreement"). The Plan and Agreement are incorporated herein in their entirety. Each RSU is equivalent to the right to receive one share of Common Stock of the Company ("<u>Share</u>") for purposes of determining the number of Shares subject to this Award. No Shares will be issued until the vesting conditions of the Award described below are satisfied and the restrictions lapse, subject to the terms and conditions set forth in the Plan and the Agreement. This Award does not entitle Grantee to any stockholder rights with respect to the underlying Shares until the vesting conditions of the Award described below are satisfied, the restrictions lapse and Shares are issued to him/her. Additional terms of this Award are as follows:

**Date of Grant: [DATE]**

**Target Number of Restricted Stock Units: [SHARES GRANTED]**

**Vesting Schedule: 100% cliff vest on [DATE] contingent on Performance Goals.**

Subject to Section 19 of the Plan, the RSUs shall vest on the Determination Date (the "Vesting Date") to the extent the RSUs have become Achieved RSUs with respect to the achievement of the performance-based vesting conditions set forth on <u>Exhibit A</u>. All vesting is contingent upon Grantee remaining a Service Provider through the Vesting Date.

**Measurement Period: twelve (12) consecutive fiscal quarter period beginning with the first day of the quarter in which the grant is approved.**

**Performance Goals:** See <u>Exhibit A</u> attached.

**<u>Termination Period</u>**. This Award automatically terminates and Grantee's rights are forfeited with respect to all RSUs granted hereunder on the date Grantee ceases to be a Service Provider (if such date precedes the Vesting Date), or in the event that Grantee has not accepted this Grant in accordance with Company procedures 31 days or more prior to the Determination Date. A portion of the Award may terminate sooner as set forth in <u>Exhibit A</u>, as a result of it not being achieved. In no event shall this Award vest later than the Vesting Schedule outlined above.

**<u>Forfeiture Events</u>**. This Award (or any portion thereof) and any Shares issued in settlement of this Award, as applicable, are subject to recoupment under any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company's securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable laws. In addition, to the extent required by Section 304 of the Sarbanes-Oxley Act of 2002, Grantee shall reimburse the Company the amount of any payment in settlement of this Award if earned or accrued under the Plan during the 12-month period following the first public issuance or filing with the Securities and Exchange Commission (whichever first occurred) of the financial document embodying such financial reporting requirement.

------

**<u>Binding Agreements</u>**. Grantee shall be deemed to have accepted this Award and the terms set forth in this Grant Notice, the Agreement, and the Plan (the "Equity Documents") until and unless the Company has received written notice via email to MicrochipStockDepartment@Microchip.com from Grantee of Grantee's non-acceptance of this Award no later than the 30<sup>th</sup> calendar day prior to the first date on which an RSU is scheduled to vest (the "Notice of Non-Acceptance"), which non-acceptance shall be irrevocable. The Equity Documents constitute Grantee's entire agreement with respect to this Award and Grantee and the Award shall be bound by the terms therein unless and until the Company receives Grantee's Notice of Non-Acceptance. The Administrator's decisions and interpretations with respect to any questions relating to the Equity Documents and/or this Award shall be binding, conclusive and final. This Award may be modified by the Company, but in accordance with Section 21(c) of the Plan, it may not be modified adversely to Grantee's interest except by means of a writing signed by the Company and Grantee. The Company will administer the Plan from the United States of America. The internal laws of the State of Arizona, United States of America, but not its choice of law principles, will govern this Award.

---

| | |
|:---|:---|
| | **MICROCHIP TECHNOLOGY INCORPORATED** |
| By: |  |
|  | Ganesh Moorthy, President and CEO |

---

**&nbsp;&nbsp;&nbsp;&nbsp;**

------

**<u>EXHIBIT A</u>**

**PERFORMANCE MATRIX**

The following terms shall apply to the Award of Restricted Stock Units granted to the Grantee identified in the Notice of Grant of Restricted Stock Units (Performance) included as part of the Agreement to which this Performance Matrix is attached. Unless otherwise defined herein, capitalized terms shall have the meanings set forth in the Plan or the Agreement, as applicable.

---

| | |
|:---|:---|
| **Operating Margin** | **Vesting Multiple\*** |
| 45% | 200% |
| 44% | 180% |
| 43% | 160% |
| 42% | 140% |
| 41% | 120% |
| 40% | 100% |
| 39% | 80% |
| 38% | 60% |
| 37% | 40% |
| 36% | 20% |
| 35% | 0% |

---

\* For performance falling between two identified "bands" in the first column of the table above, the actual vesting multiple for determining the number of RSUs vesting on the applicable Vesting Date will be calculated by linear interpolation between (a) the two identified bands and (b) the two vesting multiples set forth in the second column that correspond to the two identified Operating Margin bands.

**<u>Definitions</u>**

"**GAAP**" means Generally Accepted Accounting Principles.

"**Operating Income**" means as to the Measurement Period, the Company's non-GAAP operating income, which is determined consistent with how non-GAAP operating income is reported in the Company's press release for the applicable fiscal quarter.

"**Operating Margin**" means as to the Measurement Period, the Company's Non-GAAP Operating Income *divided by* Net Sales (rounded to the second decimal).

"**Net Sales**" means as to the Measurement Period, the Company's GAAP net sales, which is determined consistent with how GAAP net sales is reported in the Company's press release for the applicable fiscal quarter.

"**SEC**" means the U.S. Securities and Exchange Commission.

**<u>Award Determination and Payout</u>**

Except as provided under the "Change of Control" section below, following the end of each Measurement Period, the Administrator will certify whether and to what extent the performance metric has been achieved for the Measurement Period (the date of such certification, the "Determination Date").

The actual number of RSUs that will vest under the Agreement, if any, upon achievement of the performance metric will be rounded down to the nearest whole number so as to avoid fractional shares (such portion, the "Achieved RSUs"). Any RSUs that do not become Achieved RSUs will be immediately forfeited and returned to the Plan share reserve.

------

**<u>Change of Control</u>**

Notwithstanding the foregoing, if a Change of Control occurs before the last day of the Measurement Period and Grantee remains a Service Provider through immediately prior to such Change of Control, the number of Restricted Stock Units that will become Achieved RSUs will equal the greater of: (i) the Target Number of Restricted Stock Units, or (ii) the number of Restricted Stock Units determined by calculating the Vesting Multiple associated with the Company Operating Margin for an adjusted Measurement Period (the "Adjusted Measurement Period") ending on the last day of the most recent fiscal quarter ending prior to the Change of Control, rounded down to the nearest whole number so as to avoid fractional shares (the "Change of Control Achieved RSUs").

The Change of Control Achieved RSUs will vest immediately prior to the Change of Control, subject to Grantee continuing to be a Service Provider through such date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All determinations regarding the Operating Margin of the Company, and any adjusted values in the event of a Change of Control, will be made by the Compensation Committee of the Company's Board of Directors, in its sole discretion, and all such determinations will be final and binding on all parties.

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION**

I, Ganesh Moorthy, certify that:

1. I have reviewed this Form 10-Q of Microchip Technology Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and l5d-l5(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| February 2, 2023 | <u>/s/ Ganesh Moorthy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>  |
| | Ganesh Moorthy |
| | President, Chief Executive Officer, and Director |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION**

I, J. Eric Bjornholt, certify that:

1. I have reviewed this Form 10-Q of Microchip Technology Incorporated;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and l5d-l5(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| February 2, 2023 | <u>/s/ J. Eric Bjornholt&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
| | J. Eric Bjornholt |
| | Senior Vice President and Chief Financial Officer |

---

## Ex-32

**Exhibit 32**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Ganesh Moorthy, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Microchip Technology Incorporated on Form 10-Q for the period ended December 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Microchip Technology Incorporated.

---

| | |
|:---|:---|
| By: | <u>/s/ Ganesh Moorthy&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>  |
| Name: | Ganesh Moorthy |
| Title: | President, Chief Executive Officer, and Director |
| Date: | February 2, 2023 |

---

I, J. Eric Bjornholt, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Microchip Technology Incorporated on Form 10-Q for the period ended December 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Microchip Technology Incorporated.

---

| | |
|:---|:---|
| By: | <u>/s/ J. Eric Bjornholt&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>  |
| Name: | J. Eric Bjornholt |
| Title: | Senior Vice President and Chief Financial Officer |
| Date: | February 2, 2023 |

---

<br>